SolarEdge (SEDG) 10-K 20 Aug 15 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Aug. 19, 2015	Dec. 31, 2014
Document and Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Jun. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Entity Registrant Name	SolarEdge Technologies Inc
Entity Central Index Key	1,419,612
Current Fiscal Year End Date	--06-30
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		39,300,386
Entity Public Float			$ 0

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands		Jun. 30, 2015	Jun. 30, 2014
CURRENT ASSETS:
Cash and cash equivalents		$ 144,750	$ 9,754
Restricted cash		3,639	1,602
Trade receivables, net		35,428	19,267
Prepaid expenses and other accounts receivable		32,645	13,151
Inventories		73,950	25,499
Total current assets		290,412	69,273
PROPERTY AND EQUIPMENT, NET	[1]	14,717	5,351
LONG-TERM LEASE DEPOSIT AND PREPAID EXPENSES		$ 529	367
LONG-TERM DEFERRED CHARGES			7
Total assets		$ 305,658	74,998
CURRENT LIABILITIES:
Short term bank loan			13,326
Current maturities of term loan			3,474
Trade payables		$ 80,684	39,438
Employees and payroll accruals		6,814	5,210
Warranty obligations		9,431	5,496
Deferred revenues		1,676	1,729
Accrued expenses and other accounts payable		6,987	4,270
Total current liabilities		105,592	72,943
LONG-TERM LIABILITIES:
Warranty obligations		22,448	12,685
Deferred revenues		$ 8,289	4,252
Warrants to purchase convertible preferred stock			765
Term loan			$ 3,444
Lease incentive obligation		$ 2,385
Total long-term liabilities		$ 33,122	$ 21,146
COMMITMENTS AND CONTINGENT LIABILITIES
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock of $0.0001 par value - authorized: 95,000,000 and 80,772,775 shares as of June 30, 2015 and 2014, respectively; issued and outstanding: 0 and 75,422,773 shares as of June 30, 2015 and 2014, respectively. Aggregate liquidation preferences of $0 and $134,656 as of June 30, 2015 and 2014, respectively			$ 116,203
Share capital
Common stock of $0.0001 par value - Authorized: 125,000,000 and 34,939,461 shares as of June 30, 2015 and 2014, respectively; issued and outstanding: 39,297,539 and 2,809,950 shares as of June 30, 2015 and 2014, respectively		$ 4
Additional paid-in capital		287,152	$ 5,878
Accumulated other comprehensive loss		(222)	(61)
Accumulated deficit		(119,990)	(141,111)
Total stockholders' equity (deficiency)		166,944	(135,294)
Total liabilities and stockholders' equity (deficiency)		$ 305,658	$ 74,998
[1]	Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).
[2]	Represents an amount less than $1.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands		Jun. 30, 2015	Jun. 30, 2014
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value		$ 0.0001	$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares		95,000,000	80,772,775
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares		0	75,422,773
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares		0	75,422,773
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, liquidation preferences		$ 0	$ 134,656
Common stock, par value		$ 0.0001	$ 0.0001
Common stock, authorized shares		125,000,000	34,939,461
Common stock, issued shares		39,297,539	2,809,950
Common stock, outstanding shares		39,297,539	2,809,950
Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares		95,000,000
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares
Series A Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value			$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares			15,558,830
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares			15,558,830
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares			15,558,830
Series B Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value			$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares			19,010,196
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares			18,760,196
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares			18,760,196
Series C Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value			$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares			15,984,655
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares			15,984,655
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares			15,984,655
Series D Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value			$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares			16,024,251
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares			16,024,251
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares			16,024,251
Series D1 Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value			$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares			5,100,000
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares			2,165,441
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares			2,165,441
Series D2 Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value			$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares	[1]		2,598,528
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares	[1]		2,598,528
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares	[1]		2,598,528
Series D3 Convertible Preferred Stock [Member]
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, par value			$ 0.0001
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, authorized shares			6,496,315
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, issued shares			4,330,872
Convertible Preferred Series A, B, C, D, D-1, D-2, D-3 stock, outstanding shares			4,330,872
[1]	As of June 30, 2013, a total of $5,314 was received on account of preferred stock. The related 2,304,524 Series D-2 preferred stock were issued in July 2013.

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) [Abstract]
Revenues	$ 325,078	$ 133,217	$ 79,035
Cost of revenues	243,295	111,246	74,626
Gross profit	81,783	21,971	4,409
Operating expenses:
Research and development, net	22,018	18,256	15,823
Sales and marketing	24,973	17,792	12,784
General and administrative	6,535	4,294	3,262
Total operating expenses	53,526	40,342	31,869
Operating income (loss)	28,257	$ (18,371)	$ (27,460)
Other expenses	104
Financial expenses, net (Note 15)	5,077	$ 2,787	$ 612
Income (loss) before taxes on income	23,076	(21,158)	(28,072)
Taxes on income (Note 14)	1,955	220	108
Net income (loss)	$ 21,121	$ (21,378)	$ (28,180)
Net basic earnings (loss) per share of common stock	$ 0.30	$ (7.64)	$ (10.28)
Net diluted earnings (loss) per share of common stock	$ 0.27	$ (7.64)	$ (10.28)
Weighted average number of shares used in computing net basic earnings (loss) per share of common stock	11,902,911	2,798,894	2,741,370
Weighted average number of shares used in computing net diluted earnings (loss) per share of common stock	15,269,448	2,798,894	2,741,370
Other comprehensive income (loss)
Change in comprehensive income (loss) related to foreign currency translation adjustments	$ (161)	$ (35)	$ (32)
Total comprehensive income (loss)	20,960	(21,413)	(28,212)
Reconciliation of net income (loss) to net income (loss) available to common stock used for net basic earnings (loss) per share calculations
Net income (loss)	21,121	$ (21,378)	$ (28,180)
Dividends accumulated for the period	(17,550)
Net income (loss) available to shareholders of common stock	3,571	$ (21,378)	$ (28,180)
Reconciliation of net income (loss) to net income (loss) available to common stock used for net diluted earnings (loss) per share calculations
Net income (loss)	21,121	$ (21,378)	$ (28,180)
Dividends accumulated for the period	(16,971)
Net income (loss) available to shareholders of common stock	$ 4,150	$ (21,378)	$ (28,180)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY - USD ($) $ in Thousands		1 Months Ended	12 Months Ended
		Jul. 31, 2013	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Balance		$ (115,014)	$ (135,294)	$ (115,014)	$ (87,990)
Issuance of Common Stock upon exercise of employee stock options			84	51	$ 110
Receipts on account of convertible preferred stock
Equity based compensation expenses to employees and non-employee consultants			2,956	1,082	$ 1,078
Conversion of convertible preferred stock into ordinary shares			140,915
Issuance of stock during period			131,208
Exercise of warrants into common stock			$ 6,115
Exercise of warrants into common stock, shares			154,768
Change in comprehensive loss related to foreign currency translation adjustments			$ (161)	(35)	(32)
Net income (loss)			21,121	(21,378)	(28,180)
Balance			$ 166,944	$ (135,294)	$ (115,014)
Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Issuance of Convertible Preferred stock, net of issuance expenses, shares		2,304,524
Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Series E Convertible Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Convertible Preferred stock [Member]
Balance		$ 100,229	$ 116,203	$ 100,229	$ 95,234
Balance (in shares)		68,493,373	75,422,773	68,493,373	66,327,932
Issuance of Common Stock upon exercise of employee stock options
Issuance of Common Stock upon exercise of employee stock options, shares
Receipts on account of convertible preferred stock
Equity based compensation expenses to employees and non-employee consultants
Conversion of convertible preferred stock into ordinary shares			$ (140,915)
Conversion of convertible preferred stock into ordinary shares, shares			(84,743,792)
Issuance of stock during period
Number of shares of common stock sold to the public
Exercise of warrants into common stock
Exercise of warrants into common stock, shares
Change in comprehensive loss related to foreign currency translation adjustments
Net income (loss)
Balance				$ 116,203	$ 100,229
Balance (in shares)				75,422,773	68,493,373
Convertible Preferred stock [Member] | Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses					$ 4,995
Issuance of Convertible Preferred stock, net of issuance expenses, shares					2,165,441
Convertible Preferred stock [Member] | Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses				$ 5,983
Issuance of Convertible Preferred stock, net of issuance expenses, shares				2,598,528
Convertible Preferred stock [Member] | Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses				$ 9,991
Issuance of Convertible Preferred stock, net of issuance expenses, shares				4,330,872
Convertible Preferred stock [Member] | Series E Convertible Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses			$ 24,712
Issuance of Convertible Preferred stock, net of issuance expenses, shares			9,321,019
Receipt on account of Convertible Preferred stock [Member]
Balance		$ 5,314		$ 5,314
Issuance of Common Stock upon exercise of employee stock options
Receipts on account of convertible preferred stock					$ 5,314
Equity based compensation expenses to employees and non-employee consultants
Conversion of convertible preferred stock into ordinary shares
Issuance of stock during period
Exercise of warrants into common stock
Change in comprehensive loss related to foreign currency translation adjustments
Net income (loss)
Balance					$ 5,314
Receipt on account of Convertible Preferred stock [Member] | Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Receipt on account of Convertible Preferred stock [Member] | Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses				$ (5,314)
Receipt on account of Convertible Preferred stock [Member] | Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Receipt on account of Convertible Preferred stock [Member] | Series E Convertible Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Common stock [Member]
Balance	[1]
Balance (in shares)		2,782,491	2,809,950	2,782,491	2,718,381
Issuance of Common Stock upon exercise of employee stock options	[1]
Issuance of Common Stock upon exercise of employee stock options, shares			34,898	27,459	64,110
Receipts on account of convertible preferred stock
Equity based compensation expenses to employees and non-employee consultants
Conversion of convertible preferred stock into ordinary shares			$ 3
Conversion of convertible preferred stock into ordinary shares, shares			28,247,923
Issuance of stock during period			$ 1
Number of shares of common stock sold to the public			8,050,000
Exercise of warrants into common stock	[1]
Exercise of warrants into common stock, shares			154,768
Change in comprehensive loss related to foreign currency translation adjustments
Net income (loss)
Balance			$ 4
Balance (in shares)			39,297,539	2,809,950	2,782,491
Common stock [Member] | Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Issuance of Convertible Preferred stock, net of issuance expenses, shares
Common stock [Member] | Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Issuance of Convertible Preferred stock, net of issuance expenses, shares
Common stock [Member] | Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Issuance of Convertible Preferred stock, net of issuance expenses, shares
Common stock [Member] | Series E Convertible Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Issuance of Convertible Preferred stock, net of issuance expenses, shares
Additional paid in Capital [Member]
Balance		$ 4,745	$ 5,878	$ 4,745	$ 3,557
Issuance of Common Stock upon exercise of employee stock options			84	51	$ 110
Receipts on account of convertible preferred stock
Equity based compensation expenses to employees and non-employee consultants			2,956	$ 1,082	$ 1,078
Conversion of convertible preferred stock into ordinary shares			140,912
Issuance of stock during period			131,207
Exercise of warrants into common stock			$ 6,115
Change in comprehensive loss related to foreign currency translation adjustments
Net income (loss)
Balance			$ 287,152	$ 5,878	$ 4,745
Additional paid in Capital [Member] | Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Additional paid in Capital [Member] | Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Additional paid in Capital [Member] | Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Additional paid in Capital [Member] | Series E Convertible Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated other comprehensive Income (loss) [Member]
Balance		(26)	$ (61)	$ (26)	$ 6
Issuance of Common Stock upon exercise of employee stock options
Receipts on account of convertible preferred stock
Equity based compensation expenses to employees and non-employee consultants
Conversion of convertible preferred stock into ordinary shares
Issuance of stock during period
Exercise of warrants into common stock
Change in comprehensive loss related to foreign currency translation adjustments			$ (161)	$ (35)	$ (32)
Net income (loss)
Balance			$ (222)	$ (61)	$ (26)
Accumulated other comprehensive Income (loss) [Member] | Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated other comprehensive Income (loss) [Member] | Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated other comprehensive Income (loss) [Member] | Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated other comprehensive Income (loss) [Member] | Series E Convertible Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated deficit [Member]
Balance		$ (119,733)	$ (141,111)	$ (119,733)	$ (91,553)
Issuance of Common Stock upon exercise of employee stock options
Receipts on account of convertible preferred stock
Equity based compensation expenses to employees and non-employee consultants
Conversion of convertible preferred stock into ordinary shares
Issuance of stock during period
Exercise of warrants into common stock
Change in comprehensive loss related to foreign currency translation adjustments
Net income (loss)			$ 21,121	$ (21,378)	$ (28,180)
Balance			$ (119,990)	$ (141,111)	$ (119,733)
Accumulated deficit [Member] | Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated deficit [Member] | Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated deficit [Member] | Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
Accumulated deficit [Member] | Series E Convertible Preferred stock [Member]
Issuance of Convertible Preferred stock, net of issuance expenses
[1]	Represents an amount less than $1.

CONSOLIDATED STATEMENTS OF CHA6

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIENCY (Parenthetical) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Issuance of common stock in initial public offering, issuance expenses	$ 13,692
Series D-2 Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses		$ 17
Series D-3 Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses		$ 9
Series D-1 Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses			$ 5
Series E Preferred stock [Member]
Issuance of Convertible Preferred stock, issuance expenses	$ 288

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Cash flows from operating activities:
Net income (loss)	$ 21,121	$ (21,378)	$ (28,180)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation	2,253	$ 1,978	$ 1,842
Capital loss from disposal of property	$ 104
Interest expenses related to short term bank loan		$ 44	$ 6
Stock-based compensation related to employees and non-employee consultants stock options	$ 2,956	1,082	1,078
Financial expenses (income), net related to term loan	(992)	431	768
Remeasurement of warrants to purchase convertible preferred stock	5,350	(53)	40
Changes in assets and liabilities:
Inventories	(48,507)	(10,681)	(1,161)
Prepaid expenses and other accounts receivable	(19,563)	(7,409)	3,776
Trade receivables, net	(16,333)	(9,911)	(1,040)
Trade payables	41,111	19,441	(7,928)
Employees and payroll accruals	1,668	1,726	307
Warranty obligations	13,698	7,803	3,866
Deferred revenues	3,989	(500)	1,934
Accrued expenses and other accounts payable	2,530	$ (418)	$ 1,585
Lease incentive obligation	2,669
Net cash provided by (used in) operating activities	12,054	$ (17,845)	$ (23,107)
Cash flows from investing activities:
Purchase of property and equipment	(11,765)	(2,990)	(1,539)
Increase in restricted cash	(2,038)	(156)	(1,085)
Increase in long-term lease deposit	(134)	(1)	(154)
Net cash used in investing activities	(13,937)	(3,147)	(2,778)
Cash flows from financing activities:
Proceeds from short term bank loan	23,000	21,813	17,880
Repayment of short term bank loan	$ (36,326)	$ (12,447)	(17,485)
Proceeds from term loan (net of $100 transaction fee)			9,900
Repayments of term loan	$ (5,919)	$ (2,401)	(969)
Deferred charges related to term loan			$ (69)
Proceeds from initial public offering, net	$ 131,402
Receipts on account of Convertible Preferred stock			$ 5,314
Proceeds from exercise of employees and non-employee consultants stock options	$ 84	$ 51	110
Net cash provided by financing activities	136,953	17,676	19,676
Increase (decrease) in cash and cash equivalents	135,070	(3,316)	(6,209)
Cash and cash equivalents at the beginning of the period	9,754	13,142	19,437
Effect of exchange rate differences on cash and cash equivalents	(74)	(72)	(86)
Cash and cash equivalents at the end of the period	144,750	$ 9,754	$ 13,142
Supplemental disclosure of non-cash financing activities:
Deferred issuance costs related to initial public offering	194
Cashless exercise of warrants to purchase common stock	6,115
Supplemental disclosure of cash flow information:
Cash paid for interest	896	$ 1,085	$ 1,065
Cash paid for income taxes	$ 4,040	$ 92	8
Series D-1 Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net			$ 4,995
Series D-2 Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net		$ 669
Receipts on account of Convertible Preferred stock			$ 5,314
Series D-3 Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net		$ 9,991
Series E Convertible Preferred stock [Member]
Cash flows from financing activities:
Proceeds from issuance of Convertible Preferred stock, net	$ 24,712

CONSOLIDATED STATEMENTS OF CAS8

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) $ in Thousands	12 Months Ended
	Jun. 30, 2013USD ($)
CONSOLIDATED STATEMENTS OF CASH FLOWS
Proceeds from term loan, transaction fee	$ 100

GENERAL

GENERAL	12 Months Ended
	Jun. 30, 2015
GENERAL [Abstract]
GENERAL	NOTE 1:- a. SolarEdge Technologies Inc. (the “Company”) and its subsidiaries design, develop, and sell an intelligent inverter solution that maximizes power generation at the individual photovoltaic (“PV”) module level while lowering the cost of energy produced by the solar PV system and providing comprehensive and advanced safety features . b. Initial Public Offering: On March 31, 2015, the Company closed its initial public offering (“IPO”) whereby 8,050,000 1,050,000 131,208 xpenses the majority of which have already been paid by the Company. Upon the closing of the IPO, all shares of the Company's outstanding convertible preferred stock automatically converted into 28,247,923 187,671 c. As of June 30, 2015 and 2014, the Company had a major customer that accounted for approximately 24.6 19.1 d. The Company depends on two Two 79 60

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Jun. 30, 2015
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
SIGNIFICANT ACCOUNTING POLICIES	NOTE 2:- The consolidated financial statements are prepared according to United States generally accepted accounting principles (“U.S. GAAP”). a. The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to warranty obligation, warrants to purchase convertible preferred stock, contingencies, share-based compensation cost, as well as in estimates used in applying the revenue recognition policy. The Company's management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. b. The functional currency of the Company and its Israeli subsidiary is the U.S. dollar, as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future. The Company's and its Israeli subsidiary's operations are currently primarily conducted in Israel and a significant portion of its expenses are currently paid in U.S. dollars. Financing activities including loans and cash investments, are mainly made in U.S. dollars. Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are translated into U.S. dollars in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 830 (“Foreign Currency Matters”). All transaction gains and losses of the re-measurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses, as appropriate. The financial statements of the Company's German, Chinese, Australian, Canadian, Dutch, Japanese and French subsidiaries, whose functional currency is other than the U.S. dollar, have been translated into U.S dollars. Assets and liabilities have been translated using the exchange rates in effect on the balance sheet date. Statements of operations amounts have been translated using the average exchange rate for the relevant periods. The resulting translation adjustments are reported as a component of stockholders' equity (deficiency) in accumulated other comprehensive income (loss). Accumulated other comprehensive loss related to foreign currency translation adjustments, net amounted to $ 222 61 26 c. The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany transactions and balances including profits from intercompany sales not yet realized outside the Company have been eliminated upon consolidation. The Company's fiscal years 2015, 2014 and 2013 ended on June 30, 2015, 2014 d. Basic net earnings (loss) per share is computed by dividing the net earnings (loss) by the weighted-average number of shares of common stock outstanding during the period. Diluted net earnings (loss) per share is computed by giving effect to all potential shares of common stock, including stock options and convertible preferred stock, to the extent dilutive, all in accordance with FASB ASC No. 260, "Earnings Per Share." The total weighted average number of shares related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock, excluded from the calculation of diluted net earnings (loss) per share due to their anti-dilutive effect was 20,565,747 25,234,818 22,953,263 Basic and diluted earnings (loss) per share is presented in conformity with the two-class method for participating securities for the periods prior to their conversion. Under this method the earnings per share for each class of shares are calculated assuming 100% of the Company's earnings are distributed as dividends to each class of shares based on their contractual rights. In addition, since all classes other than common stock do not participate in losses, for the twelve months period ended June 30, 2014 and 2013 these shares are not included in the computation of basic loss per share. For the years ended June 30, 2014 and 2013 basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following table presents the computation of basic and diluted net earnings (loss) per share for the periods presented (in thousands, except per share data): Year ended June 30, 2015 2014 2013 Net basic earnings (loss) per share of common stock: Numerator: Net income (loss) 21,121 (21,378) (28,180) Dividends accumulated for the period (17,550) - - Net income (loss) available to shareholders of common stock 3,571 (21,378) (28,180) Denominator: Shares used in computing net earnings (loss) per share of common stock, basic 11,902,911 2,798,894 2,741,370 Net diluted earnings (loss) per share of common stock: Numerator: Net income (loss) 21,121 (21,378) (28,180) Dividends accumulated for the period (16,971) - - Net income (loss) available to shareholders of common stock 4,150 (21,378) (28,180) Denominator: Shares used in computing net earnings (loss) per share of common stock, diluted 15,269,448 2,798,894 2,741,370 e. Cash equivalents are short-term, highly liquid investments that are readily convertible to cash, with original maturities of three months or less at the date acquired. f. Restricted cash is primarily invested in short-term bank deposits, which are primarily used to guarantee a letter of credit which has been issued to one of the Company's major vendors and to the Company's landlords for its office leases. g. Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence. The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its market value. Cost of finished goods and raw materials is determined using the moving average cost method. h. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following rates: % Computers and peripheral equipment 14 33 33 Office furniture and equipment 7 15 7) Machinery & equipment 7 33 20) Laboratory equipment 15 33 15) Vehicles 15 Leasehold improvements over the shorter of the lease term or useful economic life i. The Company's long-lived assets are reviewed for impairment in accordance with ASC 360 (“ Property, Plants and Equipment”) If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. For the years ended June 30, 2015, 2014 and 2013, no impairment losses have been identified. j. Pursuant to Israel's Severance Pay Law, Israeli employees are entitled to severance pay equal to one month's salary for each year of employment, or a portion thereof. The employees of the Company's Israeli subsidiary have elected to be included under section 14 of the Severance Pay Law, 1963, under which these employees are entitled only to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary. These payments cause the Company to be released from any future obligation under the Israeli Severance Pay Law to make severance payments in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet. For the years ended June 30, 2015, 2014 and 2013, the Company recorded $ 1,273 1,109 974 k. The Company and its subsidiaries generate their revenues mainly from the sale of power optimizers, inverters and cloud-based monitoring services, to distributors, installers and PV module manufacturers. Revenues from product sales and related services are recognized in accordance with ASC 605 (“Revenue Recognition”), when persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable, collectability is reasonably assured and no significant obligations remain. Persuasive evidence of an arrangement exists Delivery has occurred The fee is fixed or determinable. Collectability is reasonably assured Provisions for rebates, sales incentives, and discounts to customers are accounted for as reductions in revenue in the same period the related sales are recorded. The Company increases a credit limit only after it has established a successful collection history with the Customer. If the Company determines at any time that collectability is not reasonably assured under a particular arrangement based upon its credit review process, the Customer's payment history or information that comes to light about a Customer's financial position, it recognizes revenue under that arrangement as Customer payments are actually received. Revenues related to cloud-based monitoring services are recognized ratably on a straight-line basis over the estimated service period of 25 For multiple-element arrangements, the Company allocates revenue to all deliverables based on their relative selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”), (ii) third-party evidence of selling price (“TPE”), and (iii) best estimate of the selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company's best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company has allocated revenue between its deliverables based on their relative selling prices. Because the Company has neither VSOE nor TPE for its deliverables, the allocation of revenue has been based on the Company's ESPs. Amounts allocated to the delivered elements are recognized at the time of sale provided the other conditions for revenue recognition have been met. The Company's process for determining its ESP considers multiple factors that may vary depending upon the unique facts and circumstances related to each deliverable. Key factors considered by the Company in developing the ESPs for its products include prices charged by the Company for similar offerings, the Company's historical pricing practices and product-specific business objectives. Deferred revenues consist of deferred web-based monitoring services, advance payments received from Customers for the Company's products and warranty extensions, and are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized. l. Cost of revenues sold includes the following: product costs consisting of purchases from contract manufacturers and other suppliers, indirect manufacturing, support, warranty, provision for loss related to slow moving and dead inventory, personnel and logistics costs. m. Shipping and handling costs, which amounted to $ 26,931 14,066 5,140 n. The Company's products include a minimum 12 25 25 The Company has established a reliability measurement system based on the units' estimated mean time between failure, or MTBF, a metric that equates to a steady-state failure rate per year for current generation products. The MTBF represents the predicted mean elapsed time to each product unit failure during system operation. The Company performs accelerated life cycle testing, which simulates the service life of the product in a short period of time. The accelerated life cycle tests incorporate test methodologies derived from standard tests used by solar module vendors to evaluate the period over which solar modules wear out. Corresponding replacement costs are updated periodically to reflect changes in the Company's actual and estimated production costs for its products. In addition, through the collection of actual failure statistics, the Company has identified several additional failure causes that are not included in the MTBF calculations. Such causes, which mostly consist of workmanship errors caused during the manufacturing process and replacement of non-faulty units by installers, are in addition to the replacement costs projected under the MTBF model. The Company identified each of those causes, its failure pattern and the relative ratio compared to the pattern of malfunctions identified under the MTBF and accrued additional provisions for the occurrence of such malfunctioning. The Company evaluates the continuation of these occurrences and the appearance of potential additional malfunctioning cases beyond the MTBF pattern and accrues additional expenses accordingly. Warranty obligations are classified as short-term and long-term warranty obligations based on the period in which the warranty is expected to be claimed. o. Royalty-bearing grants from the Binational Industrial Research and Development Foundation (“BIRD-F”) for funding of approved research and development projects are recognized, as a deduction from research and development expenses, The Company recorded grants from BIRD-F in the amount of $ 248 p. Government grants received by the Company's Israeli subsidiary relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the expenditure to which they relate is charged. Royalty bearing grants from the Israeli Office of the Chief Scientist (“OCS”) for funding certain approved research and development projects are recognized at the time when the Company's Israeli subsidiary is entitled to such grants, on the basis of the related costs incurred, and are included as a deduction from research and development expenses. The Company recorded grants in the amount of $ 763 275 q. Research and development costs, net of grants received, are charged to the consolidated statement of operations as incurred. r. Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, trade receivables and other accounts receivable. Cash and cash equivalents are mainly invested in major banks in the U.S., Israel and in Germany. Management believes that the financial institutions that hold the Company's investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments. The trade receivables of the Company are derived from sales to Customers located primarily in North America and Europe. The Company generally does not require collateral, except for a partial advance payment; however, in certain circumstances, the Company may require letters of credit, other collateral or additional guarantees. 13 As of June 30, 2015 and 2014, the Company had a major Customer which accounted for approximately 30 31 The Company and its subsidiaries have no off-balance sheet concentration of credit risk except for certain derivative instruments as mentioned below. s. The following methods and assumptions were used by the Company in estimating the fair value of its financial instruments: The carrying value of cash and cash equivalents, restricted cash, trade receivables, prepaid expenses and other accounts receivable, short term bank loan, trade payables, employees and payroll accruals and accrued expenses and other accounts payable approximate their fair values due to the short-term maturities of such instruments. Assets measured at fair value on a recurring basis as of June 30, 2015 are comprised of foreign currency forward contracts. Assets and liabilities measured at fair value on a recurring basis as of June 30, 2014 and 2013 are comprised of foreign currency forward contracts and warrants to purchase convertible preferred stock liability related to term loan (see Note 8). The Company applies ASC 820 (“Fair Value Measurements and Disclosures”), with respect to fair value measurements of all financial assets and liabilities. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value: Level 1- Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2- Include other inputs that are directly or indirectly observable in the marketplace. Level 3- Unobservable inputs which are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. In accordance with ASC 820, the Company measures its foreign currency derivative contracts, at fair value using the market approach valuation technique. Foreign currency derivative contracts as detailed in Note 2w are classified within the Level 2 value hierarchy, as the valuation inputs are based on quoted prices and market observable data of similar instruments. Warrants to purchase convertible preferred stock as detailed in Note 8 are classified within the Level 3 value hierarchy. t. The Company accounts for freestanding warrants to purchase shares of its convertible preferred stock as a liability on the balance sheets at fair value. The warrants to purchase convertible preferred stock are recorded as a liability because of a provision calling for minimum proceeds upon or after an “Exit Event”, as described in Note 8. The fair value of warrants to purchase convertible preferred stock on the issuance date and on subsequent reporting dates was determined using a hybrid method utilizing the assumptions noted below. The fair value of the underlying preferred stock price was determined by the board of directors considering, among others, third party valuations. The valuation of the Company was performed using the hybrid method, a hybrid between the probability-weighted estimated return method (“PWERM”) and Option Pricing Method (“OPM”) estimating the probability-weighted value across multiple scenarios but using the OPM to estimate the allocation of value within one or more of those scenarios. The OPM was used to allocate the Company's equity value between the preferred stock, common stock and warrants in a scenario of other liquidation events. The expected terms of the warrants were based on the remaining contractual expiration period. The expected share price volatility for the shares was determined by examining the historical volatilities of a group of the Company's industry peers as there was insufficient trading history of the Company's shares. The risk-free interest rate was calculated using the average of the published interest rates for U.S. Treasury zero-coupon issues with maturities that approximate the expected term. The dividend yield assumption was zero as there is no history of dividend payments and since the Company does not expect to pay any didivends in the foreseeable future. The following assumptions were used to estimate the value of the warrants to purchase June 30, 2014 2013 Expected volatility 45.0 55.8 Risk-free rate 0.09 0.3 Dividend yield 0 0 Expected term (in years) 1.21 1.50 The warrants to purchase convertible preferred stock were subject to re-measurement to fair value at each balance sheet date and any change in fair value was recognized as a component of financial expenses, net, on the statements of operations. The change in the fair value of warrants to purchase convertible preferred stock is summarized below: Balance at Issuance of warrants to Exercise of warrants to Change in fair value Balance at June 30, 2015 $ 765 $ - $ (6,115) $ 5,350 $ - June 30, 2014 $ 818 $ - $ - $ (53) $ 765 June 30, 2013 $ - $ 778 $ - $ 40 $ 818 (*) Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 On June 18, 2015 the warrants were cashless exercised into 154,768 u. The Company accounts for stock-based compensation in accordance with ASC 718 (“Compensation-Stock Compensation”). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (“OPM”). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statements of operations. The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Estimated forfeitures are based on actual historical pre-vesting forfeitures. The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its stock-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying common stock, expected stock price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with SAB No. 110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has not declared or paid any dividends on its common stock and does not expect to pay any dividends in the foreseeable future. The fair value of the shares of common stock underlying the stock options has historically been determined by the Company's management and approved by the board of directors. Because there has been no public market for the Company's common stock, the Company's management has determined fair value of the common stock by using, among other factors, third party valuations at the time of grant of the option by considering a number of objective and subjective factors, including data from other comparable companies, issuance of convertible preferred stock to unrelated third parties, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook. The fair value of the underlying common stock was determined by the management until such time as the Company's common stock is listed on an established stock exchange or national market system. The Company's management determined the value of the shares of common stock based on valuations performed using the OPM for the years ended June 30, 2014 and 2013 and for the period from July 1, 2014 and up to March 31, 2015. From March 31, 2015 the common stock is publicly traded. Since the distributions and participation rights to security holders until March 31, 2015 are different in a sale/liquidation scenario versus an IPO, the valuation of the Company's equity was performed using a discounted cash flow (DCF) model or a new investment round by external investors. The allocation of the Company's equity value between the convertible preferred stock, common stock and warrants was performed using a hybrid method between the PWERM and OPM estimating the probability-weighted value across multiple scenarios for liquidation events other than an IPO. Before the per share value was determined, a discount for lack of marketability and a voting right differential was applied, as applicable, to the common stock. The fair value for options granted to employees and executive directors in the year ended June 30, 2015, 2014 and 2013 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions: Year ended June 30, 2015 2014 2013 Risk-free interest 1.39 2.06 1.62 1.94 0.74 1.00 Dividend yields 0 0 0 Volatility 46.5 55.1 46.3 55.8 55.8 62.7 Expected option term 5.50 6.27 6.02 6.27 6.08 6.27 Estimated forfeiture rate 12.5 18.7 14.0 14.5 20.9 The following table set forth the parameters used in computation of the options compensation Year ended June 30, 2015 2014 2013 Risk-free interest 1.49 2.58 1.95 2.45 0.98 1.96 Dividend yields 0 0 0 Volatility 45.5 56.2 45.0 55.8 55.8 62.7 Contractual life 7.2 10.0 6.0 10.0 7.0 10.0 The Company and its subsidiaries account for income taxes in accordance with ASC 740, “Income Taxes.” ASC 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates that will be in effect when the differences are expected to reverse. The Company and its subsidiaries provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value. The Company accounts for uncertain tax positions in accordance with ASC 740. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits under taxes on income. w. The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company entered into derivative instrument arrangements to hedge the Company's exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses were recorded immediately in the statement of operations, as financial expenses, net. As of June 30, 2015, 2014 and 2013, the Company recorded the fair value of derivative instruments in the amount of $ 859 213 258 x. The Company reports comprehensive income (loss) in accordance with ASC 220 (“Comprehensive Income”). ASC 220 establishes standards for the reporting and presentation of comprehensive income and its components in a full set of general purpose financial statements. Total comprehensive income (loss) and the components of accumulated other comprehensive income (loss) are presented in the consolidated statements of stockholders' equity (deficiency). Accumulated other comprehensive income (loss) consists of foreign currency translation effects. y. In May 2014, the FASB issued an accounting standard update on revenue from contracts with customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The new guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. On July 9, 2015, the FASB agreed to delay the effective date by one year. In accordance with the agreed upon delay, the new standard is effective for the Company beginning January 1st, 2018. Early adoption is permitted, but not before the original effective date of the standard. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting. z.

PREPAID EXPENSES AND OTHER ACCO

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE	12 Months Ended
	Jun. 30, 2015
PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE [Abstract]
PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE	NOTE 3:- June 30, 2015 2014 Contract manufacturers (*) $ 24,814 $ 10,234 Government authorities 3,729 646 OCS 249 - Prepaid expenses and other 2,994 2,038 Foreign currency derivative contracts 859 213 Deferred charges (see Note 8) - 20 $ 32,645 $ 13,151 (*) Contract manufacturers receivables derive from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in revenues (see also Note 10e).

INVENTORIES

INVENTORIES	12 Months Ended
	Jun. 30, 2015
INVENTORIES [Abstract]
INVENTORIES	NOTE 4:- June 30, 2015 2014 Raw materials $ 14,405 $ 7,750 Finished goods 59,545 17,749 $ 73,950 $ 25,499 The Company recorded inventory write-downs of $ 992 1,131 428

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	12 Months Ended
	Jun. 30, 2015
PROPERTY AND EQUIPMENT [Abstract]
PROPERTY AND EQUIPMENT	NOTE 5 :- PROPERTY AND EQUIPMENT June 30, 2015 2014 Cost: Computers and peripheral equipment $ 3,139 $ 3,193 Office furniture and equipment 779 404 Laboratory and testing equipment 7,205 5,856 Machinery and equipment 6,936 2,491 Leasehold improvements 4,047 353 Vehicles 13 - 22,119 12,297 Less - accumulated depreciation 7,402 6,946 Depreciated cost $ 14,717 $ 5,351 Depreciation expenses for the years ended June 30, 2015, 2014 and 2013 were $ 2,253 1,978 1,842

ACCRUED EXPENSES AND OTHER ACCO

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE	12 Months Ended
	Jun. 30, 2015
ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE [Abstract]
ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE	NOTE 6:- ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE June 30, 2015 2014 Accrued expenses $ 5,271 $ 2,807 Provision for contractual inventory purchase obligations * 1,304 1,317 OCS - 146 Other 412 - $ 6,987 $ 4,270 * See also Note 10e.

WARRANTY OBLIGATIONS

WARRANTY OBLIGATIONS	12 Months Ended
	Jun. 30, 2015
WARRANTY OBLIGATIONS [Abstract]
WARRANTY OBLIGATIONS	NOTE 7 :- WARRANTY OBLIGATIONS Changes in the Company's product warranty liability for the years ended on June 30, 2015 and 2014 were as follows: June 30, 2015 2014 Balance, at beginning of year $ 18,181 $ 10,378 Additions and adjustments to cost of revenues 19,407 11,861 Usage and current warranty expenses (5,709 ) (4,058 ) Balance, at end of year 31,879 18,181 Less current portion (9,431 ) (5,496 ) Long term portion $ 22,448 $ 12,685

TERM LOAN AND WARRANTS TO PURCH

TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK	12 Months Ended
	Jun. 30, 2015
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Abstract]
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK	NOTE 8 :- TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK On December 28, 2012 (the “Agreement Date”), the Company entered into a loan facility agreement (the “Loan Agreement”) with a lender (the “Lender”), pursuant to which the Lender agreed to loan the Company up to $ 10,000 10,000 100 42 11.90 33 Borrowings pursuant to the Loan Agreement are secured by a first priority security interest in all existing and future assets of the Company, ranking junior to the Bank Lender's security interest as to the Company's trade receivables, inventory and cash and ranking pari passu with the Bank Lender's security interest as to all other collateral, including all equipment, intellectual property and all outstanding share capital of SolarEdge Technologies GmbH, SolarEdge Technologies Inc. and SolarEdge Technologies (China) Co., Ltd. (see Note 9). In connection with the Loan Agreement, the Company granted the Lender 563,014 2.309 12 If (i) the Lender exercised all Warrants in full upon or after an Exit Event, and (ii) the intrinsic value of the Warrants upon such exercise is lower than $ 750 On the Agreement Date, the Company recorded its freestanding Warrants to purchase its convertible preferred stock in the amount of $ 778 Upon exercise or expiration, the Warrants will be reclassified to stockholders' equity (deficiency), at which time the Warrant liability will no longer be subject to fair value accounting. The fair value of the Warrants liability on the Agreement Date in the amount of $778 represented a loan discount which was amortized to financial expenses over the period of the Loan by using the effective interest method. The residual amount of $ 9,122 Issuance expenses in the amount of $ 75 6 69 Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 As of June 30, 2014, the Warrants liability has been measured at fair value in the amount of $ 765 In January 2015, the Company fully settled the amount borrowed from Kreos under the Term Loan. On June 18, 2015 the Lender elected to exersice its cashless exercise rights under which the Company issued 154,768 6,115

REVOLVING CREDIT LINE

REVOLVING CREDIT LINE	12 Months Ended
	Jun. 30, 2015
REVOLVING CREDIT LINE [Abstract]
REVOLVING CREDIT LINE	NOTE 9 :- REVOLVING CREDIT LINE In June 2011, the Company entered into an agreement for a revolving line of credit from a Bank Lender (the "Bank Lender"), which, as amended to date, permits aggregate borrowings of up to $ 20 80 65 Bank Lender's prime rate 0.75 2.75 4.9 On February 17, 2015, the Company amended and restated the agreement with the Bank Lender for a revolving line of credit, which permits aggregate borrowings of up to $ 40 80 Bank Lender's prime rate 0.5 2.0 December 31, 2016 In connection with the amended and restated revolving line of credit, the Company granted the Bank Lender security interests in substantially all of the Company's assets, including a first-priority security interest in the Company's trade receivables, cash and cash equivalents. Financial covenants contained in the agreement require the Company to maintain EBITDA and liquidity at specified levels. Specifically, the Company is required to maintain negative Adjusted EBITDA (defined in accordance with US GAAP as (a) net income, plus (b) the extent deducted in the calculation of net income, interest, taxes, depreciation and amortization, plus (c) to the extent deducted in the calculation of net income, non-cash stock-based compensation) of no greater than ($1,500 1,500 3,500 1,500 3,500 The Company is required to maintain liquidity (defined as unrestricted and unencumbered cash, plus availability under the amended and restated revolving line of credit) of $ 6,750 The amended and restated revolving line of credit also contains covenants that restrict the Company's ability to dispose of assets, engage in business combinations (or permit a subsidiary to engage in business combinations), grant liens, borrow money, or pay dividends. As of June 30, 2015 and 2014 the Company met all its Bank Lender covenants. As of June 30, 2015 the Company had no outstanding borrowings related to this revolving line of credit.

COMMITMENTS AND CONTINGENT LIAB

COMMITMENTS AND CONTINGENT LIABILITIES	12 Months Ended
	Jun. 30, 2015
COMMITMENTS AND CONTINGENT LIABILITIES [Abstract]
COMMITMENTS AND CONTINGENT LIABILITIES	NOTE 10 :- COMMITMENTS AND CONTINGENT LIABILITIES a. Lease commitments: The Company and its subsidiaries lease their operating facilities under non-cancelable operating lease agreements, which expire over the next ten years, with the last ending in December 2024. The future minimum lease commitments of the Company and its subsidiaries under various non-cancelable operating lease agreements in respect of premises, that are in effect as of June 30, 2015, are as follows: 2016 $ 2,256 2017 2,218 2018 2,156 2019 2,042 2020 and thereafter 8,706 $ 17,378 Rent expenses for the years ended June 30, 2015, 2014 and 2013 were approximately $ 1,714 1,200 1,212 b. Guarantees: As of June 30, 2015, contingent liabilities exist regarding guarantees in the amount of $ 813 53 85 c. Royalty commitments: On April 12, 2009, the Company received approval for a grant in a total amount of $ 703 Under the Company's research and development agreements with the BIRD-F, and pursuant to applicable law, the Company is required to pay royalties at the rate of 5 150 At the end of 2011, the American corporation that had partnered with the Company announced the discontinuation of its solar business, resulting in the termination of the mutual development agreements. As a result, the development has not advanced into a commercial product. The Company does not expect any revenues from such project or the utilization of the technology mutually developed. As of June 30, 2015, the aggregate contingent liability to the BIRD-F amounted to approximately $ 1,135 d. Governmental commitments: The Company has received royalty-bearing grants sponsored by the Israeli government for the support of research and development activities. Through June 30, 2015, the Company had obtained grants from the OCS for certain of the Company's research and development projects. The Company is obligated to pay royalties to the OCS, amounting to 4 three 4.5 of the sales of the products and other related revenues (based on the dollar equivalent amount of the grant) generated from such projects, up to 100 of the grants received. The royalty payment obligations also bear interest at the LIBOR rate. The obligation to pay these royalties is contingent on actual sales of the applicable products and in the absence of such sales, no payment is required. As of June 30, 2015 and 2014, there have been no sales or revenues on which royalties are payables. As of June 30, 2015, the aggregate contingent liability to the OCS amounted to $ 771 The Israeli Research and Development Law provides that know-how developed under an approved research and development program may not be transferred to third parties without the approval of the OCS. Such approval is not required for the sale or export of any products resulting from such research or development. The OCS, under special circumstances, may approve the transfer of OCS-funded know-how outside Israel, in the following cases: (a) the grant recipient pays to the OCS a portion of the sale price paid in consideration for such OCS-funded know-how or in consideration for the sale of the grant recipient itself, as the case may be, which portion will not exceed six times the amount of the grants received plus interest (or three times the amount of the grant received plus interest, in the event that the recipient of the know-how has committed to retain the R&D activities of the grant recipient in Israel after the transfer); (b) the grant recipient receives know-how from a third party in exchange for its OCS-funded know-how; (c) such transfer of OCS-funded know-how arises in connection with certain types of cooperation in research and development activities; or (d) if such transfer of know-how arises in connection with a liquidation by reason of insolvency or receivership of the grant recipient. e. Contractual purchase obligations: The Company has contractual obligations to purchase goods and raw materials. These contractual purchase obligations relate to inventories held by contract manufacturers and purchase orders initiated by the contract manufacturers, which cannot be canceled without penalty. The Company utilizes third parties to manufacture its products. In addition, it acquires raw materials or other goods and services, including product components, by issuing to suppliers authorizations to purchase based on its projected demand and manufacturing needs. As of June 30, 2015, the Company had non-cancelable purchase obligations totaling approximately 92,071 1,304 f. Legal claims: 1. From time to time, the Company may be involved in various claims and legal proceedings. The Company reviews the status of each matter and assesses its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount can be reasonably estimated, the Company accrues a liability for the estimated loss. These accruals are reviewed at least quarterly and adjusted to reflect the impact of negotiations, settlements, rulings, advice of legal counsel and other information and events pertaining to a particular matter. 2. On February 6, 2012, SolarEdge Technologies Ltd. (“SolarEdge”) was served with a lawsuit filed by Appletech Ltd. (“Appletech”) in the Tel Aviv-Jaffa Court in an amount of NIS 2,208,000 642 lleging that SolarEdge owes payment under a manufacturing agreement and purchase orders. SolarEdge maintained that if any amounts should be deemed due, they would need to be offset with damages caused by Appletech and incurred by SolarEdge. SolarEdge filed a countersuit. The parties agreed to a summary judgment proceeding which was held in July 2014. On July 24, 2014, the judge ruled that SolarEdge is to pay NIS 1,725,000 502 45 A liability was recorded in the financial statements as of June 30, 2013 and 2014, and the amount of the judgment was paid in September 2014.

LEASE INCENTIVE OBLIGATION

LEASE INCENTIVE OBLIGATION	12 Months Ended
	Jun. 30, 2015
LEASE INCENTIVE OBLIGATION [Abstract]
LEASE INCENTIVE OBLIGATION	NOTE 11 :- LEASE INCENTIVE OBLIGATION The Company has a new operating lease agreement for building in Herzilia, Israel. In connection with this lease, the Company and its third party lessor (the "Lessor"), agreed that the Lessor would pay approximately $ 2,811 As of June 30, 2015 the Company had received in cash 2,313 from the Lessor. These leasehold improvements are accounted for as a lease incentive obligation, which is recorded under long-term liabilities, net of the current portion recorded in accrued expenses and other accounts payable under current liabilities. The lease incentive obligation is being amortized over the life of the lease and as a reduction to rent expense.

CONVERTIBLE PREFERRED STOCK

CONVERTIBLE PREFERRED STOCK	12 Months Ended
	Jun. 30, 2015
CONVERTIBLE PREFERRED STOCK [Abstract]
CONVERTIBLE PREFERRED STOCK	NOTE 12 :- CONVERTIBLE PREFERRED STOCK Composition of convertible preferred stock of the Company: Authorized Issued and outstanding Number of shares June 30, 2015 2014 2015 2014 Stock of $0.0001 par value: Preferred stock 95,000,000 - - - Series A Preferred stock - 15,558,830 - 15,558,830 Series B Preferred stock - 19,010,196 - 18,760,196 Series C Preferred stock - 15,984,655 - 15,984,655 Series D Preferred stock - 16,024,251 - 16,024,251 Series D-1 Preferred stock - 5,100,000 - 2,165,441 Series D-2 Preferred stock (*) - 2,598,528 - 2,598,528 Series D-3 Preferred stock - 6,496,315 - 4,330,872 Series E Preferred stock(**) - - - - 95,000,000 80,772,775 - 75,422,773 (*) As of June 30, 2013, a total of $ 5,314 The related 2,304,524 Series D-2 preferred stock were issued in July 2013. (**) In September 2014, the Company entered into a stock purchase agreement with new investors, pursuant to which the Company issued 9,321,019 25,000 The Company issued Series A through E Preferred stock between the years 2006 and 2015. The Company classified the convertible preferred stock outside of stockholders' equity (deficiency) as required by ASC 480-10-S99-3A and ASR 268, since the shares possessed deemed liquidation features that could trigger a distribution of cash or assets not solely within the Company's control. Prior to the consummation of the Company's IPO on March 31, 2015, the Company had the following convertible preferred stock outstanding, all of which was converted into common stock following with the IPO on March 31, 2015 (see Note 1b) which resulted in classification of convertible preferred stock temporary equity in the amount 140,915 Shares Outstanding Number of Shares of Common Stock issued upon conversion Series A Preferred stock 15,558,830 5,186,276 Series B Preferred stock 18,760,196 6,253,398 Series C Preferred stock 15,984,655 5,328,217 Series D Preferred stock 16,024,251 5,341,416 Series D-1 Preferred stock 2,165,441 721,813 Series D-2 Preferred stock 2,598,528 866,175 Series D-3 Preferred stock 4,330,872 1,443,623 Series E Preferred stock 9,321,019 3,107,005 84,743,792 28,247,923

STOCK CAPITAL

STOCK CAPITAL	12 Months Ended
	Jun. 30, 2015
STOCK CAPITAL [Abstract]
STOCK CAPITAL	NOTE 1 3 :- STOCK CAPITAL a. Composition of common stock capital of the Company: Authorized Issued and outstanding Number of shares June 30, June 30, 2015 2014 2015 201 4 Stock of $ 0.0001 Common stock 125,000,000 34,939,461 39,297,539 2,809,950 b. Common stock rights: Common stock confers upon its holders the right to receive notice of, and to participate in, all general meetings of the Company, where each share of common stock shall have one vote for all purposes; to share equally, on a per share basis, in bonuses, profits or distributions out of fund legally available therefor; and to participate in the distribution of the surplus assets of the Company in the event of liquidation of the Company. c. On March 23, 2015, the Company's board of directors and the requisite holders of the Company's capital stock consented to a 1-for- 3 d. As a result of the reverse stock split, (i) every 3 shares of authorized, issued and outstanding common stock was decreased to one e. Stock option plans: The Company's 2007 Global Incentive Plan (the “2007 Plan”) was adopted by the board of directors on August 30, 2007. The 2007 Plan terminated upon the Company's IPO on March 31, 2015 and no further awards may be granted thereunder. All outstanding awards will continue to be governed by their existing terms and 379,358 vailable options for future grant were transferred to the Company's 2015 Global Incentive Plan (the “2015 Plan”) and are reserved for future issuances under the 2015 plan. The 2015 Plan became effective upon the consummation of the IPO. The 2015 Plan provides for the grant of options, RSUs and other share-based awards to directors, employees, officers and consultants of the Company and its Subsidiaries. As of June 30, 2015, a total of 1,822,484 shares of common stock were reserved for issuance pursuant to stock awards under the 2015 Plan (the “Share Reserve”). The Share Reserve will automatically increase on January 1st of each year during the term of the 2015 Plan commencing on January 1st of the year following the year in which the 2015 Plan becomes effective in an amount equal to 5 of the total number of shares of capital stock outstanding on December 31st of the preceding calendar year; provided, however, that the Company's board of directors may determine that there will not be a January 1st increase in the Share Reserve in a given year or that the increase will be less than 5 of the shares of capital stock outstanding on the preceding December 31st. The aggregate maximum number of shares of common stock that may be issued on the exercise of incentive stock options is 10,000,000 As of June 30, 2015, an aggregate of 1,755,044 In addition, the Company adopted an Employee Stock Purchase Plan (the “ESPP”) effective upon the consummation of the IPO. As of June 30, 2015, a total of 487,643 ten 1 However, the Company's board of directors may reduce the amount of the increase in any particular year at their discretion, including a reduction to zero. A summary of the activity in the share options granted to employees and members of the board of directors for the year ended June 30, 2015 and related information follows: Weighted a verage Weighted remaining Number average contractual Aggregate of exercise term intrinsic options price in years Value Outstanding as of July 1, 2014 4,007,116 $ 2.13 6.82 $ 6,384 Granted 2,183,563 $ 4.89 Exercised (31,981 ) $ 2.36 Forfeited or expired (56,476 ) $ 3.42 Outstanding as of June 30, 2015 6,102,222 $ 3.10 7.08 $ 202,889 Vested and expected to vest as of June 30, 2015 5,809,767 $ 3.04 7.00 $ 193,518 Exercisable as of June 30, 2015 3,551,239 $ 2.17 5.71 $ 121,373 A summary of the activity in the share options granted to employees and members of the board of directors for the year ended June 30, 2014 and related information follows: Weighted a verage Weighted remaining Number average contractual Aggregate of exercise term intrinsic options price in years Value Outstanding as of July 1, 2013 3,625,366 $ 1.92 7.39 $ 5,757 Granted 575,457 $ 3.41 Exercised (27,459 ) $ 1.86 Forfeited or expired (166,248 ) $ 2.16 Outstanding as of June 30, 2014 4,007,116 $ 2.13 6.82 $ 6,384 Vested and expected to vest as of June 30, 2014 3,746,620 $ 2.07 6.69 $ 6,175 Exercisable as of June 30, 2014 2,719,543 $ 1.81 6.08 $ 5,206 The aggregate intrinsic value in the tables above represents the total intrinsic value (the difference between the fair value of the Company's common stock as of the last day of each period and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last day of each period. The total intrinsic value of options exercised during the year ended June 30, 2015 and 2014 was $ 484 58 The weighted average grant date fair values of options granted to employees and executive directors during the years ended June 30, 2015, 2014 and 2013 were $ 7.57 0.66 0.52 The options outstanding as of June 30, 2015, have been separated into exercise price ranges as follows: Options Weighted Options Weighted outstanding average exercisable average Range of as of remaining as of remaining exercise June 30, contractual June 30, contractual price 201 5 Life in years 201 5 Life in years $ 0.87 557,605 3.94 490,165 3.14 $ 1.50 1.68 771,321 4.04 771,321 4.04 $ 2.01 2.46 2,075,550 6.30 1,794,228 6.24 $ 3.03 3.96 668,270 8.54 247,767 8.46 $ 5.01 5.04 1,996,148 9.42 247,758 9.40 $ 9.36 33,328 9.59 - - 6,102,222 7.08 3,551,239 5.71 The options outstanding as of June 30, 201 4 , have been separated into exercise price ranges as follows: Options Weighted Options Weighted outstanding average exercisable average Range of as of remaining as of remaining exercise June 30, contractual June 30, contractual price 201 4 L ife in years 201 4 L ife in years $ 0.87 490,165 4.14 490,165 4.14 $ 1.50 1.68 779,653 5.05 774,185 5.05 $ 2.01 2.46 2,114,517 7.31 1,388,628 7.19 $ 3.03 3.51 622,781 9.46 66,565 9.19 4,007,116 6.82 2,719,543 6.08 Options issued to non-employee consultants: a. The Company has granted options to purchase common shares to non-employee consultants as of June 30, 2015 as follows: Options outstanding Exercisable as of as of Issuance June 30, Exercise June 30, Exercisable Date 2015 price 2015 Through July 31, 2008 33,333 $ 0.87 33,333 July 31, 2018 January 26, 2011 5,000 $ 2.01 5,000 January 26, 2021 January 26, 2012 33,333 $ 2.46 33,333 January 26, 2022 October 24, 2012 6,666 $ 2.46 4,583 October 24, 2022 January 23, 2013 3,333 $ 3.03 2,153 January 23, 2023 January 27, 2014 4,998 $ 3.51 1,652 January 27, 2024 May 1, 2014 6,000 $ 3.51 2,042 May 1, 2024 September 17, 2014 19,163 $ 3.96 3,662 September 17, 2024 October 29, 2014 6,668 $ 5.01 890 October 29, 2024 118,494 86,648 b. The Company has granted options to purchase common shares to non-employee consultants as of June 30, 2014 as follows: Options outstanding Exercisable as of as of Issuance June 30, Exercise June 30, Exercisable D ate 201 4 price 201 4 Through July 31, 2008 33,333 $ 0.87 33,333 July 31, 2018 January 26, 2011 5,000 $ 2.01 5,000 January 26, 2021 January 26, 2012 33,333 $ 2.46 27,778 January 26, 2022 October 24, 2012 6,666 $ 2.46 2,916 October 24, 2022 January 23, 2013 8,333 $ 3.03 3,298 January 23, 2023 January 27, 2014 4,998 $ 3.51 139 January 27, 2024 May 1, 2014 6,000 $ 3.51 - May 1, 2024 97,663 72,464 The Company accounts for its options granted to non-employee consultants under the fair value method of ASC 505-50 (“Equity-Based Payments to Non-Employees”). In connection with the grant of stock options to non-employee consultants, the Company recorded stock compensation expenses in the years ended June 30, 2015, 2014 and 2013 in the amounts of $ 563 55 45 Stock-based compensation expense for employees and non-employee consultants: The Company recognized stock-based compensation expenses related to stock options granted to employees and non-employee consultants in the consolidated statement of operations for the years ended June 30, 2015, 2014 and 2013, as follows: Year ended 2015 2014 2013 Cost of revenues $ 442 $ 108 $ 88 Research and development, net 635 397 381 Selling and marketing 809 297 317 General and administrative 1,070 280 292 Total stock-based compensation expense $ 2,956 $ 1,082 $ 1,078 As of June 30, 2015, there was a total unrecognized compensation expense of 10,577 related to non-vested equity-based compensation arrangements granted under the Company's Plan. These expenses are expected to be recognized during the period from July 1, 2015 through October 31, 2019.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Jun. 30, 2015
INCOME TAXES [Abstract]
INCOME TAXES	NOTE 14:- a. Tax rates in U.S. and Germany: The Company is subject to U.S. federal tax at the rate of 35 33 b. Corporate tax in Israel: Taxable income of Israeli companies is subject to corporate tax at the rate of 25 26.5 c. Carryforward tax losses: As of June 30, 2015, the Israeli subsidiary has approximately $ 84,700 As of June 30, 2015, the Company has no As of June 30, 2015 , the Company has net operating loss carryforwards for California income tax purposes of approximately $ 9,794 d. Deferred income taxes: Deferred income taxes reflect the net tax effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. June 30, 2015 2014 Assets in respect of: Carryforward tax losses (1) $ 23,033 $ 32,203 Research and Development carryforward expenses- temporary differences 5,173 4,310 Other reserves 1,346 786 29,552 37,299 Valuation allowance (2) (29,552 ) (37,299 ) Net deferred tax assets $ - $ - (1) See Note 14c. (2) The Company has provided full valuation allowances as of June 30, 2015 and 2014 on deferred tax assets resulting from carryforward tax losses, research and development carryforward expenses and other reserves due to its history of operating losses and current uncertainty concerning the ability to realize these deferred tax assets in the future. Undistributed earnings of certain subsidiaries as of June 30, 2015 were immaterial. The Company intends to reinvest these earnings indefinitely in the foreign subsidiaries. As a result, the Company has not provided for any deferred income taxes. e. Income (loss) before taxes is comprised as follows: Year ended June 30, 2015 2014 Domestic $ 2,830 $ 661 Foreign 20,246 (21,819 ) $ 23,076 $ (21,158 ) f. Taxes on income are comprised as follows: Year ended June 30, 2015 2014 2013 Federal $ 1,270 $ 11 $ - State 180 89 - Foreign 300 120 108 Taxes on income related to prior years 205 - - $ 1,955 $ 220 $ 108 g. The differences between the statutory tax rate of the Company and the effective tax rate are primarily accounted for by the non-recognition of tax benefits from accumulated net carryforward tax losses among the Company and various subsidiaries due to uncertainty of the realization of such tax benefits. A reconciliation between the theoretical tax expense, assuming all income is taxed at the statutory tax rate applicable to income of the Company, and the actual tax expense (benefit) as reported in the consolidated statements of operations is as follows: Year ended June 30, 2015 2014 2013 Income (loss) before taxes, as reported in the consolidated statements of operations $ 23,076 $ (21,158 ) $ (28,072 ) Statutory tax rate 35 35 35 Theoretical tax benefits on the above amount at the US statutory tax rate 8,077 (7,405 ) (9,825 ) Income tax at rate other than the U.S. statutory tax rate (1,763 ) 2,007 2,167 Impact of Israel corporate tax rate change from 25% to 26.5% - (2,103 ) - Taxes on income related to prior years 205 - - Non-deductible expenses including equity based compensation expenses 3,003 467 300 Operating losses and other temporary differences for which valuation allowance was provided (7,747 ) 7,165 7,466 State tax 180 89 - Actual tax expense $ 1,955 $ 220 $ 108 h. Tax assessments: As of June 30, 2015, the Company and certain of its subsidiaries filed U.S. federal and various state and foreign income tax returns. The statute of limitations relating to the consolidated U.S. federal income tax return is closed for all tax years up to and including 2011. The statute of limitations related to tax returns of the Company's Israeli subsidiary is closed for all tax years up to and including 2010. With respect to the Company's German, Chinese, Australian, Canadian, Dutch, Japaneese, UK and French subsidiaries, the statute of limitations related to its tax returns is open for all tax years since incorporation. The Company believes that it has adequately provided for any reasonably foreseeable outcome related to tax audits and settlements. The final tax outcome of any Company tax audits could be different from that which is reflected in the Company's income tax provisions and accruals. Such differences could have a material effect on the Company's income tax provision and net income (loss) in the period in which such determination is made. i. Tax benefits for Israeli companies under the Law for the Encouragement of Capital Investments, 1959 (the “Investment Law”): The Israeli subsidiary elected tax year 2012 as a "Year of Election" for “Beneficiary Enterprise” status under the Investment Law, which provides certain benefits, including tax exemptions and reduced tax rates. Income not eligible for Beneficiary Enterprise benefits is taxed at a regular corporate tax rate. Upon meeting the requirements under the Investment Law, income derived from Beneficiary Enterprise from productive activity will be exempt from tax for two 12 If dividends are distributed out of tax exempt profits, the Israeli subsidiary will then become liable for tax at the rate applicable to its profits from the Beneficiary Enterprise in the year in which the income was earned, as if it had not chosen the alternative track of benefits. The dividend recipient is subject to withholding tax at the rate of 15 Through June 30, 2015, the Israeli subsidiary had not generated income under the provision of the Investment Law. In December 2010, the Israeli Parliament passed the Law for Economic Policy for 2011 and 2012 (Amended Legislation), which, among other things, included an amendment to the Investment Law, effective as of January 1, 2011 (the “Amendment”). In accordance with the 2011 Amendment, the benefit tracks under the Investment Law were modified and a uniform tax rate would apply to companies eligible for the “Preferred Enterprise” status (rather than the previous terminology of “Beneficiary Enterprise”). Companies may elect to irrevocably implement the 2011 Amendment (while waiving benefits provided under the Investment Law as then in effect). On July 30, 2013, the Israeli Parliament passed a law, which, among other things, was designated to amend the uniform tax rates that were set in the 2011 Amendment, and to increase the tax levy for years 2013 and 2014 (the “New Law”). The New Law increases the Israeli corporate tax rate from 25% to 26.5%, cancels the reduction of corporate tax rate for “Preferred Enterprises”, which was set at 16 20 The Israeli subsidiary currently does not intend to implement the Amendment. j. Tax benefits under Israel's Law for Encouragement of Industry (Taxation), 1969: The Israeli entity is an "industrial company" under the Law for the Encouragement of Industry (Taxation), 1969, and as such is entitled to certain tax benefits, mainly the amortization of costs relating to know-how and patents, over eight The following corporate tax benefits, among others, are available to Industrial Companies: amortization of the cost of purchased a patent, rights to use a patent, and know-how, which are used for the development or advancement of the company, over an eight-year period, commencing on the year in which such rights were first exercised; under limited conditions, an election to file consolidated tax returns with related Israeli Industrial Companies; and expenses related to a public offering are deductible in equal amounts over three Eligibility for benefits under the Industry Encouragement Law is not contingent upon approval of any governmental authority. There can be no assurance that the Company will continue to qualify as an Industrial Company or that the benefits described above will be available in the future.

FINANCIAL EXPENSES (INCOME), NE

FINANCIAL EXPENSES (INCOME), NET	12 Months Ended
	Jun. 30, 2015
FINANCIAL EXPENSES (INCOME), NET [Abstract]
FINANCIAL EXPENSES (INCOME), NET	NOTE 15:- FINANCIAL EXPENSES (INCOME), NET Year ended June 30, 2015 2014 2013 Remeasurement of warrants to purchase convertible preferred stock $ 5,350 $ (53 ) $ 40 Interest on term loan 579 1,475 794 Other financial expenses related to term loan 373 31 21 Expenses (income) related to hedging transaction (1,721 ) 189 (207 ) Interest on short- term loan 316 537 276 Exchange rate loss (income), net, bank charges and other finance expenses 180 608 (312 ) $ 5,077 $ 2,787 $ 612

GEOGRAPHIC INFORMATION AND MAJO

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA	12 Months Ended
	Jun. 30, 2015
GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA [Abstract]
GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA	NOTE 16:- Summary information about geographic areas: ASC 280 ( “ Segment Reporting ” ) establishes standards for reporting information about operating segments. Operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker in deciding how to allocate resources and in assessing performance. The Company manages its business on the basis of one of the Company ' s business). The following is a summary of revenues within geographic areas : Year ended June 30, 2015 2014 2013 Revenues based on Customers' location: United States $ 238,340 $ 64,607 $ 15,334 Germany 13,290 15,133 12,692 Europe (*) 52,163 38,655 40,367 Rest of the World 21,285 14,822 10,642 Total revenues $ 325,078 $ 133,217 $ 79,035 (*) Except for Germany Major C ustomers data as a percentage of total revenues: Year ended June 30, 2015 2014 2013 Customer A 24.6 19.1% * *) Less than 10%. The following is a summary of revenues by product family : Year ended June 30, 2015 2014 2013 Inverters $ 156,984 $ 62,085 $ 35,422 Optimizers 158,513 65,018 38,337 Others 9,581 6,114 5,276 Total revenues $ 325,078 $ 133,217 $ 79,035 Long-lived assets by geographic region : Year ended June 30, 2015 2014 Israel $ 14,136 $ 5,025 Europe 230 211 U.S. 342 112 Other 9 3 Total long-lived assets* $ 14,717 $ 5,351 * Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Jun. 30, 2015
SUBSEQUENT EVENTS [Abstract]
SUBSEQUENT EVENTS	NOTE 17:- On January 9, 2015, a patent infringement lawsuit was filed by Beacon Power LLC, a Delaware limited liability company (“Beacon”), against the Company and a third party in the United States District Court for the Western District of Texas, San Antonio Division which alleges infringement by the Company of two U.S. patents. On March 9, 2015, the Company and Beacon entered into a patent purchase agreement under which the Company agreed to purchase all rights in the aforementioned patents and Beacon agreed to dismiss all outstanding claims against the Company. In July 2015 the Company completed the purchase in return for total consideration of $ 800

SIGNIFICANT ACCOUNTING POLICI26

SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Jun. 30, 2015
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Use of estimates	a. The preparation of financial statements, in conformity with U.S. GAAP, requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company evaluates on an ongoing basis its assumptions, including those related to warranty obligation, warrants to purchase convertible preferred stock, contingencies, share-based compensation cost, as well as in estimates used in applying the revenue recognition policy. The Company's management believes that the estimates, judgment and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.
Financial statements in U.S. dollars	b. The functional currency of the Company and its Israeli subsidiary is the U.S. dollar, as the U.S. dollar is the currency of the primary economic environment in which the Company has operated and expects to continue to operate in the foreseeable future. The Company's and its Israeli subsidiary's operations are currently primarily conducted in Israel and a significant portion of its expenses are currently paid in U.S. dollars. Financing activities including loans and cash investments, are mainly made in U.S. dollars. Accordingly, monetary accounts maintained in currencies other than the U.S. dollar are translated into U.S. dollars in accordance with Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 830 (“Foreign Currency Matters”). All transaction gains and losses of the re-measurement of monetary balance sheet items are reflected in the statements of operations as financial income or expenses, as appropriate. The financial statements of the Company's German, Chinese, Australian, Canadian, Dutch, Japanese and French subsidiaries, whose functional currency is other than the U.S. dollar, have been translated into U.S dollars. Assets and liabilities have been translated using the exchange rates in effect on the balance sheet date. Statements of operations amounts have been translated using the average exchange rate for the relevant periods. The resulting translation adjustments are reported as a component of stockholders' equity (deficiency) in accumulated other comprehensive income (loss). Accumulated other comprehensive loss related to foreign currency translation adjustments, net amounted to $ 222 61 26
Principles of consolidation	c. The consolidated financial statements include the accounts of the Company and its subsidiaries. Intercompany transactions and balances including profits from intercompany sales not yet realized outside the Company have been eliminated upon consolidation. The Company's fiscal years 2015, 2014 and 2013 ended on June 30, 2015, 2014
Basic and Diluted Net Earnings (Loss) Per Share	d. Basic net earnings (loss) per share is computed by dividing the net earnings (loss) by the weighted-average number of shares of common stock outstanding during the period. Diluted net earnings (loss) per share is computed by giving effect to all potential shares of common stock, including stock options and convertible preferred stock, to the extent dilutive, all in accordance with FASB ASC No. 260, "Earnings Per Share." The total weighted average number of shares related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock, excluded from the calculation of diluted net earnings (loss) per share due to their anti-dilutive effect was 20,565,747 25,234,818 22,953,263 Basic and diluted earnings (loss) per share is presented in conformity with the two-class method for participating securities for the periods prior to their conversion. Under this method the earnings per share for each class of shares are calculated assuming 100% of the Company's earnings are distributed as dividends to each class of shares based on their contractual rights. In addition, since all classes other than common stock do not participate in losses, for the twelve months period ended June 30, 2014 and 2013 these shares are not included in the computation of basic loss per share. For the years ended June 30, 2014 and 2013 basic and diluted net loss per share was the same for each period presented as the inclusion of all potential shares of common stock outstanding would have been anti-dilutive. The following table presents the computation of basic and diluted net earnings (loss) per share for the periods presented (in thousands, except per share data): Year ended June 30, 2015 2014 2013 Net basic earnings (loss) per share of common stock: Numerator: Net income (loss) 21,121 (21,378) (28,180) Dividends accumulated for the period (17,550) - - Net income (loss) available to shareholders of common stock 3,571 (21,378) (28,180) Denominator: Shares used in computing net earnings (loss) per share of common stock, basic 11,902,911 2,798,894 2,741,370 Net diluted earnings (loss) per share of common stock: Numerator: Net income (loss) 21,121 (21,378) (28,180) Dividends accumulated for the period (16,971) - - Net income (loss) available to shareholders of common stock 4,150 (21,378) (28,180) Denominator: Shares used in computing net earnings (loss) per share of common stock, diluted 15,269,448 2,798,894 2,741,370
Cash and cash equivalents	e. Cash equivalents are short-term, highly liquid investments that are readily convertible to cash, with original maturities of three months or less at the date acquired.
Restricted cash	f. Restricted cash is primarily invested in short-term bank deposits, which are primarily used to guarantee a letter of credit which has been issued to one of the Company's major vendors and to the Company's landlords for its office leases.
Inventories	g. Inventories are stated at the lower of cost or market value. Inventory reserves are provided to cover risks arising from slow-moving items or technological obsolescence. The Company periodically evaluates the quantities on hand relative to historical, current and projected sales volume. Based on this evaluation, an impairment charge is recorded when required to write-down inventory to its market value. Cost of finished goods and raw materials is determined using the moving average cost method.
Property and equipment	h. Property and equipment are stated at cost, net of accumulated depreciation. Depreciation is calculated by the straight-line method over the estimated useful lives of the assets, at the following rates: % Computers and peripheral equipment 14 33 33 Office furniture and equipment 7 15 7) Machinery & equipment 7 33 20) Laboratory equipment 15 33 15) Vehicles 15 Leasehold improvements over the shorter of the lease term or useful economic life
Impairment of long-lived assets	i. The Company's long-lived assets are reviewed for impairment in accordance with ASC 360 (“ Property, Plants and Equipment”) If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds their fair value. For the years ended June 30, 2015, 2014 and 2013, no impairment losses have been identified.
Severance pay	j. Pursuant to Israel's Severance Pay Law, Israeli employees are entitled to severance pay equal to one month's salary for each year of employment, or a portion thereof. The employees of the Company's Israeli subsidiary have elected to be included under section 14 of the Severance Pay Law, 1963, under which these employees are entitled only to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary. These payments cause the Company to be released from any future obligation under the Israeli Severance Pay Law to make severance payments in respect of those employees; therefore, related assets and liabilities are not presented in the balance sheet. For the years ended June 30, 2015, 2014 and 2013, the Company recorded $ 1,273 1,109 974
Revenue recognition	k. The Company and its subsidiaries generate their revenues mainly from the sale of power optimizers, inverters and cloud-based monitoring services, to distributors, installers and PV module manufacturers. Revenues from product sales and related services are recognized in accordance with ASC 605 (“Revenue Recognition”), when persuasive evidence of an arrangement exists, delivery has occurred, the selling price is fixed or determinable, collectability is reasonably assured and no significant obligations remain. Persuasive evidence of an arrangement exists Delivery has occurred The fee is fixed or determinable. Collectability is reasonably assured Provisions for rebates, sales incentives, and discounts to customers are accounted for as reductions in revenue in the same period the related sales are recorded. The Company increases a credit limit only after it has established a successful collection history with the Customer. If the Company determines at any time that collectability is not reasonably assured under a particular arrangement based upon its credit review process, the Customer's payment history or information that comes to light about a Customer's financial position, it recognizes revenue under that arrangement as Customer payments are actually received. Revenues related to cloud-based monitoring services are recognized ratably on a straight-line basis over the estimated service period of 25 For multiple-element arrangements, the Company allocates revenue to all deliverables based on their relative selling prices. In such circumstances, the Company uses a hierarchy to determine the selling price to be used for allocating revenue to deliverables: (i) vendor-specific objective evidence of fair value (“VSOE”), (ii) third-party evidence of selling price (“TPE”), and (iii) best estimate of the selling price (“ESP”). VSOE generally exists only when the Company sells the deliverable separately and is the price actually charged by the Company for that deliverable. ESPs reflect the Company's best estimates of what the selling prices of elements would be if they were sold regularly on a stand-alone basis. The Company has allocated revenue between its deliverables based on their relative selling prices. Because the Company has neither VSOE nor TPE for its deliverables, the allocation of revenue has been based on the Company's ESPs. Amounts allocated to the delivered elements are recognized at the time of sale provided the other conditions for revenue recognition have been met. The Company's process for determining its ESP considers multiple factors that may vary depending upon the unique facts and circumstances related to each deliverable. Key factors considered by the Company in developing the ESPs for its products include prices charged by the Company for similar offerings, the Company's historical pricing practices and product-specific business objectives. Deferred revenues consist of deferred web-based monitoring services, advance payments received from Customers for the Company's products and warranty extensions, and are classified as short-term and long-term deferred revenues based on the period in which revenues are expected to be recognized.
Cost of revenues	l. Cost of revenues sold includes the following: product costs consisting of purchases from contract manufacturers and other suppliers, indirect manufacturing, support, warranty, provision for loss related to slow moving and dead inventory, personnel and logistics costs.
Shipping and handling costs	m. Shipping and handling costs, which amounted to $ 26,931 14,066 5,140
Warranty obligations	n. The Company's products include a minimum 12 25 25 The Company has established a reliability measurement system based on the units' estimated mean time between failure, or MTBF, a metric that equates to a steady-state failure rate per year for current generation products. The MTBF represents the predicted mean elapsed time to each product unit failure during system operation. The Company performs accelerated life cycle testing, which simulates the service life of the product in a short period of time. The accelerated life cycle tests incorporate test methodologies derived from standard tests used by solar module vendors to evaluate the period over which solar modules wear out. Corresponding replacement costs are updated periodically to reflect changes in the Company's actual and estimated production costs for its products. In addition, through the collection of actual failure statistics, the Company has identified several additional failure causes that are not included in the MTBF calculations. Such causes, which mostly consist of workmanship errors caused during the manufacturing process and replacement of non-faulty units by installers, are in addition to the replacement costs projected under the MTBF model. The Company identified each of those causes, its failure pattern and the relative ratio compared to the pattern of malfunctions identified under the MTBF and accrued additional provisions for the occurrence of such malfunctioning. The Company evaluates the continuation of these occurrences and the appearance of potential additional malfunctioning cases beyond the MTBF pattern and accrues additional expenses accordingly. Warranty obligations are classified as short-term and long-term warranty obligations based on the period in which the warranty is expected to be claimed.
Royalty-bearing grants from the Binational Industrial Research and Development Foundation	o. Royalty-bearing grants from the Binational Industrial Research and Development Foundation (“BIRD-F”) for funding of approved research and development projects are recognized, as a deduction from research and development expenses, The Company recorded grants from BIRD-F in the amount of $ 248
Government grants	p. Government grants received by the Company's Israeli subsidiary relating to categories of operating expenditures are credited to the consolidated statements of operations during the period in which the expenditure to which they relate is charged. Royalty bearing grants from the Israeli Office of the Chief Scientist (“OCS”) for funding certain approved research and development projects are recognized at the time when the Company's Israeli subsidiary is entitled to such grants, on the basis of the related costs incurred, and are included as a deduction from research and development expenses. The Company recorded grants in the amount of $ 763 275
Research and development costs	q. Research and development costs, net of grants received, are charged to the consolidated statement of operations as incurred.
Concentrations of credit risks	r. Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, trade receivables and other accounts receivable. Cash and cash equivalents are mainly invested in major banks in the U.S., Israel and in Germany. Management believes that the financial institutions that hold the Company's investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments. The trade receivables of the Company are derived from sales to Customers located primarily in North America and Europe. The Company generally does not require collateral, except for a partial advance payment; however, in certain circumstances, the Company may require letters of credit, other collateral or additional guarantees. 13 As of June 30, 2015 and 2014, the Company had a major Customer which accounted for approximately 30 31 The Company and its subsidiaries have no off-balance sheet concentration of credit risk except for certain derivative instruments as mentioned below.
Fair value of financial instruments	s. The following methods and assumptions were used by the Company in estimating the fair value of its financial instruments: The carrying value of cash and cash equivalents, restricted cash, trade receivables, prepaid expenses and other accounts receivable, short term bank loan, trade payables, employees and payroll accruals and accrued expenses and other accounts payable approximate their fair values due to the short-term maturities of such instruments. Assets measured at fair value on a recurring basis as of June 30, 2015 are comprised of foreign currency forward contracts. Assets and liabilities measured at fair value on a recurring basis as of June 30, 2014 and 2013 are comprised of foreign currency forward contracts and warrants to purchase convertible preferred stock liability related to term loan (see Note 8). The Company applies ASC 820 (“Fair Value Measurements and Disclosures”), with respect to fair value measurements of all financial assets and liabilities. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or a liability. A three-tier fair value hierarchy is established as a basis for considering such assumptions and for inputs used in the valuation methodologies in measuring fair value: Level 1- Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets. Level 2- Include other inputs that are directly or indirectly observable in the marketplace. Level 3- Unobservable inputs which are supported by little or no market activity. The fair value hierarchy also requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. In accordance with ASC 820, the Company measures its foreign currency derivative contracts, at fair value using the market approach valuation technique. Foreign currency derivative contracts as detailed in Note 2w are classified within the Level 2 value hierarchy, as the valuation inputs are based on quoted prices and market observable data of similar instruments. Warrants to purchase convertible preferred stock as detailed in Note 8 are classified within the Level 3 value hierarchy.
Warrants to Purchase Convertible Preferred Stock	t. The Company accounts for freestanding warrants to purchase shares of its convertible preferred stock as a liability on the balance sheets at fair value. The warrants to purchase convertible preferred stock are recorded as a liability because of a provision calling for minimum proceeds upon or after an “Exit Event”, as described in Note 8. The fair value of warrants to purchase convertible preferred stock on the issuance date and on subsequent reporting dates was determined using a hybrid method utilizing the assumptions noted below. The fair value of the underlying preferred stock price was determined by the board of directors considering, among others, third party valuations. The valuation of the Company was performed using the hybrid method, a hybrid between the probability-weighted estimated return method (“PWERM”) and Option Pricing Method (“OPM”) estimating the probability-weighted value across multiple scenarios but using the OPM to estimate the allocation of value within one or more of those scenarios. The OPM was used to allocate the Company's equity value between the preferred stock, common stock and warrants in a scenario of other liquidation events. The expected terms of the warrants were based on the remaining contractual expiration period. The expected share price volatility for the shares was determined by examining the historical volatilities of a group of the Company's industry peers as there was insufficient trading history of the Company's shares. The risk-free interest rate was calculated using the average of the published interest rates for U.S. Treasury zero-coupon issues with maturities that approximate the expected term. The dividend yield assumption was zero as there is no history of dividend payments and since the Company does not expect to pay any didivends in the foreseeable future. The following assumptions were used to estimate the value of the warrants to purchase June 30, 2014 2013 Expected volatility 45.0 55.8 Risk-free rate 0.09 0.3 Dividend yield 0 0 Expected term (in years) 1.21 1.50 The warrants to purchase convertible preferred stock were subject to re-measurement to fair value at each balance sheet date and any change in fair value was recognized as a component of financial expenses, net, on the statements of operations. The change in the fair value of warrants to purchase convertible preferred stock is summarized below: Balance at Issuance of warrants to Exercise of warrants to Change in fair value Balance at June 30, 2015 $ 765 $ - $ (6,115) $ 5,350 $ - June 30, 2014 $ 818 $ - $ - $ (53) $ 765 June 30, 2013 $ - $ 778 $ - $ 40 $ 818 (*) Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 On June 18, 2015 the warrants were cashless exercised into 154,768
Accounting for stock-based compensation	u. The Company accounts for stock-based compensation in accordance with ASC 718 (“Compensation-Stock Compensation”). ASC 718 requires companies to estimate the fair value of equity-based payment awards on the date of grant using an Option-Pricing Model (“OPM”). The value of the portion of the award that is ultimately expected to vest is recognized as an expense over the requisite service periods in the Company's consolidated statements of operations. The Company recognizes compensation expenses for the value of its awards granted based on the straight-line method over the requisite service period of each of the awards, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Estimated forfeitures are based on actual historical pre-vesting forfeitures. The Company selected the Black-Scholes-Merton option pricing model as the most appropriate fair value method for its stock-option awards. The option-pricing model requires a number of assumptions, of which the most significant are the fair market value of the underlying common stock, expected stock price volatility and the expected option term. Expected volatility was calculated based upon certain peer companies that the Company considered to be comparable. The expected option term represents the period of time that options granted are expected to be outstanding. The expected option term is determined based on the simplified method in accordance with SAB No. 110, as adequate historical experience is not available to provide a reasonable estimate. The simplified method will continue to apply until enough historical experience is available to provide a reasonable estimate of the expected term. The risk-free interest rate is based on the yield from U.S. treasury bonds with an equivalent term. The Company has not declared or paid any dividends on its common stock and does not expect to pay any dividends in the foreseeable future. The fair value of the shares of common stock underlying the stock options has historically been determined by the Company's management and approved by the board of directors. Because there has been no public market for the Company's common stock, the Company's management has determined fair value of the common stock by using, among other factors, third party valuations at the time of grant of the option by considering a number of objective and subjective factors, including data from other comparable companies, issuance of convertible preferred stock to unrelated third parties, operating and financial performance, the lack of liquidity of capital stock and general and industry specific economic outlook. The fair value of the underlying common stock was determined by the management until such time as the Company's common stock is listed on an established stock exchange or national market system. The Company's management determined the value of the shares of common stock based on valuations performed using the OPM for the years ended June 30, 2014 and 2013 and for the period from July 1, 2014 and up to March 31, 2015. From March 31, 2015 the common stock is publicly traded. Since the distributions and participation rights to security holders until March 31, 2015 are different in a sale/liquidation scenario versus an IPO, the valuation of the Company's equity was performed using a discounted cash flow (DCF) model or a new investment round by external investors. The allocation of the Company's equity value between the convertible preferred stock, common stock and warrants was performed using a hybrid method between the PWERM and OPM estimating the probability-weighted value across multiple scenarios for liquidation events other than an IPO. Before the per share value was determined, a discount for lack of marketability and a voting right differential was applied, as applicable, to the common stock. The fair value for options granted to employees and executive directors in the year ended June 30, 2015, 2014 and 2013 is estimated at the date of grant using a Black-Scholes-Merton option pricing model with the following assumptions: Year ended June 30, 2015 2014 2013 Risk-free interest 1.39 2.06 1.62 1.94 0.74 1.00 Dividend yields 0 0 0 Volatility 46.5 55.1 46.3 55.8 55.8 62.7 Expected option term 5.50 6.27 6.02 6.27 6.08 6.27 Estimated forfeiture rate 12.5 18.7 14.0 14.5 20.9 The following table set forth the parameters used in computation of the options compensation Year ended June 30, 2015 2014 2013 Risk-free interest 1.49 2.58 1.95 2.45 0.98 1.96 Dividend yields 0 0 0 Volatility 45.5 56.2 45.0 55.8 55.8 62.7 Contractual life 7.2 10.0 6.0 10.0 7.0 10.0
Income taxes	The Company and its subsidiaries account for income taxes in accordance with ASC 740, “Income Taxes.” ASC 740 prescribes the use of the liability method, whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates that will be in effect when the differences are expected to reverse. The Company and its subsidiaries provide a valuation allowance, if necessary, to reduce deferred tax assets to their estimated realizable value. The Company accounts for uncertain tax positions in accordance with ASC 740. ASC 740-10 contains a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position taken or expected to be taken in a tax return by determining if the weight of available evidence indicates that it is more likely than not that, on an evaluation of the technical merits, the tax position will be sustained on audit, including resolution of any related appeals or litigation processes. The second step is to measure the tax benefit as the largest amount that is more than 50% (cumulative probability) likely to be realized upon ultimate settlement. The Company accrues interest and penalties related to unrecognized tax benefits under taxes on income.
Derivative financial instruments	w. The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company entered into derivative instrument arrangements to hedge the Company's exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses were recorded immediately in the statement of operations, as financial expenses, net. As of June 30, 2015, 2014 and 2013, the Company recorded the fair value of derivative instruments in the amount of $ 859 213 258
Comprehensive income (loss)	x. The Company reports comprehensive income (loss) in accordance with ASC 220 (“Comprehensive Income”). ASC 220 establishes standards for the reporting and presentation of comprehensive income and its components in a full set of general purpose financial statements. Total comprehensive income (loss) and the components of accumulated other comprehensive income (loss) are presented in the consolidated statements of stockholders' equity (deficiency). Accumulated other comprehensive income (loss) consists of foreign currency translation effects.
Impact of recently issued accounting standards	y. In May 2014, the FASB issued an accounting standard update on revenue from contracts with customers, which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers. The new guidance will replace most existing revenue recognition guidance in U.S. GAAP when it becomes effective. On July 9, 2015, the FASB agreed to delay the effective date by one year. In accordance with the agreed upon delay, the new standard is effective for the Company beginning January 1st, 2018. Early adoption is permitted, but not before the original effective date of the standard. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. The Company is currently evaluating the effect that the new guidance will have on its consolidated financial statements and related disclosures. The Company has not yet selected a transition method nor has it determined the effect of the standard on its ongoing financial reporting.
Reclassification	z.

SIGNIFICANT ACCOUNTING POLICI27

SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Jun. 30, 2015
SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Schedule of computation of basic and diluted net earnings (loss) per share	Year ended June 30, 2015 2014 2013 Net basic earnings (loss) per share of common stock: Numerator: Net income (loss) 21,121 (21,378) (28,180) Dividends accumulated for the period (17,550) - - Net income (loss) available to shareholders of common stock 3,571 (21,378) (28,180) Denominator: Shares used in computing net earnings (loss) per share of common stock, basic 11,902,911 2,798,894 2,741,370 Net diluted earnings (loss) per share of common stock: Numerator: Net income (loss) 21,121 (21,378) (28,180) Dividends accumulated for the period (16,971) - - Net income (loss) available to shareholders of common stock 4,150 (21,378) (28,180) Denominator: Shares used in computing net earnings (loss) per share of common stock, diluted 15,269,448 2,798,894 2,741,370
Schedule of estimated useful lives of property and equipment	% Computers and peripheral equipment 14 33 33 Office furniture and equipment 7 15 7) Machinery & equipment 7 33 20) Laboratory equipment 15 33 15) Vehicles 15 Leasehold improvements over the shorter of the lease term or useful economic life
Summary of change in fair value of warrants to purchase convertible preferred stock	Balance at Issuance of warrants to Exercise of warrants to Change in fair value Balance at June 30, 2015 $ 765 $ - $ (6,115) $ 5,350 $ - June 30, 2014 $ 818 $ - $ - $ (53) $ 765 June 30, 2013 $ - $ 778 $ - $ 40 $ 818
Warrants to purchase convertible preferred stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of assumptions used to estimate fair value of stock options and warrants	June 30, 2014 2013 Expected volatility 45.0 55.8 Risk-free rate 0.09 0.3 Dividend yield 0 0 Expected term (in years) 1.21 1.50
Stock Option [Member] | Employees and executive directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of assumptions used to estimate fair value of stock options and warrants	Year ended June 30, 2015 2014 2013 Risk-free interest 1.39 2.06 1.62 1.94 0.74 1.00 Dividend yields 0 0 0 Volatility 46.5 55.1 46.3 55.8 55.8 62.7 Expected option term 5.50 6.27 6.02 6.27 6.08 6.27 Estimated forfeiture rate 12.5 18.7 14.0 14.5 20.9
Stock Option [Member] | Non-employee consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Schedule of assumptions used to estimate fair value of stock options and warrants	Year ended June 30, 2015 2014 2013 Risk-free interest 1.49 2.58 1.95 2.45 0.98 1.96 Dividend yields 0 0 0 Volatility 45.5 56.2 45.0 55.8 55.8 62.7 Contractual life 7.2 10.0 6.0 10.0 7.0 10.0

PREPAID EXPENSES AND OTHER AC28

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE (Tables)	12 Months Ended
	Jun. 30, 2015
PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE [Abstract]
Schedule of prepaid expenses and other accounts receivable	June 30, 2015 2014 Contract manufacturers (*) $ 24,814 $ 10,234 Government authorities 3,729 646 OCS 249 - Prepaid expenses and other 2,994 2,038 Foreign currency derivative contracts 859 213 Deferred charges (see Note 8) - 20 $ 32,645 $ 13,151

INVENTORIES (Tables)

INVENTORIES (Tables)	12 Months Ended
	Jun. 30, 2015
INVENTORIES [Abstract]
Schedule of inventories	June 30, 2015 2014 Raw materials $ 14,405 $ 7,750 Finished goods 59,545 17,749 $ 73,950 $ 25,499

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	12 Months Ended
	Jun. 30, 2015
PROPERTY AND EQUIPMENT [Abstract]
Schedule of property and equipment	June 30, 2015 2014 Cost: Computers and peripheral equipment $ 3,139 $ 3,193 Office furniture and equipment 779 404 Laboratory and testing equipment 7,205 5,856 Machinery and equipment 6,936 2,491 Leasehold improvements 4,047 353 Vehicles 13 - 22,119 12,297 Less - accumulated depreciation 7,402 6,946 Depreciated cost $ 14,717 $ 5,351

ACCRUED EXPENSES AND OTHER AC31

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE (Tables)	12 Months Ended
	Jun. 30, 2015
ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE [Abstract]
Schedule of accrued expenses and other accounts payable	June 30, 2015 2014 Accrued expenses $ 5,271 $ 2,807 Provision for contractual inventory purchase obligations * 1,304 1,317 OCS - 146 Other 412 - $ 6,987 $ 4,270 * See also Note 10e.

WARRANTY OBLIGATIONS (Tables)

WARRANTY OBLIGATIONS (Tables)	12 Months Ended
	Jun. 30, 2015
WARRANTY OBLIGATIONS [Abstract]
Schedule of warranty obligations	June 30, 2015 2014 Balance, at beginning of year $ 18,181 $ 10,378 Additions and adjustments to cost of revenues 19,407 11,861 Usage and current warranty expenses (5,709 ) (4,058 ) Balance, at end of year 31,879 18,181 Less current portion (9,431 ) (5,496 ) Long term portion $ 22,448 $ 12,685

COMMITMENTS AND CONTINGENT LI33

COMMITMENTS AND CONTINGENT LIABILITIES (Tables)	12 Months Ended
	Jun. 30, 2015
COMMITMENTS AND CONTINGENT LIABILITIES [Abstract]
Schedule of future minimum lease commitments	2016 $ 2,256 2017 2,218 2018 2,156 2019 2,042 2020 and thereafter 8,706 $ 17,378

CONVERTIBLE PREFERRED STOCK (Ta

CONVERTIBLE PREFERRED STOCK (Tables)	12 Months Ended
	Jun. 30, 2015
CONVERTIBLE PREFERRED STOCK [Abstract]
Schedule of composition of convertible preferred stock	Authorized Issued and outstanding Number of shares June 30, 2015 2014 2015 2014 Stock of $0.0001 par value: Preferred stock 95,000,000 - - - Series A Preferred stock - 15,558,830 - 15,558,830 Series B Preferred stock - 19,010,196 - 18,760,196 Series C Preferred stock - 15,984,655 - 15,984,655 Series D Preferred stock - 16,024,251 - 16,024,251 Series D-1 Preferred stock - 5,100,000 - 2,165,441 Series D-2 Preferred stock (*) - 2,598,528 - 2,598,528 Series D-3 Preferred stock - 6,496,315 - 4,330,872 Series E Preferred stock(**) - - - - 95,000,000 80,772,775 - 75,422,773 (*) As of June 30, 2013, a total of $ 5,314 The related 2,304,524 Series D-2 preferred stock were issued in July 2013. (**) In September 2014, the Company entered into a stock purchase agreement with new investors, pursuant to which the Company issued 9,321,019 25,000
Schedule of convertible preferred stock outstanding prior to consummation of IPO	Shares Outstanding Number of Shares of Common Stock issued upon conversion Series A Preferred stock 15,558,830 5,186,276 Series B Preferred stock 18,760,196 6,253,398 Series C Preferred stock 15,984,655 5,328,217 Series D Preferred stock 16,024,251 5,341,416 Series D-1 Preferred stock 2,165,441 721,813 Series D-2 Preferred stock 2,598,528 866,175 Series D-3 Preferred stock 4,330,872 1,443,623 Series E Preferred stock 9,321,019 3,107,005 84,743,792 28,247,923

STOCK CAPITAL (Tables)

STOCK CAPITAL (Tables)	12 Months Ended
	Jun. 30, 2015
STOCK CAPITAL [Abstract]
Schedule of composition of common stock capital	Authorized Issued and outstanding Number of shares June 30, June 30, 2015 2014 2015 201 4 Stock of $ 0.0001 Common stock 125,000,000 34,939,461 39,297,539 2,809,950
Option [Member] | Employees and members of the board of directors [Member]
STOCK CAPITAL
Summary of the activity in the share options granted to employees and members of the board of directors	Weighted a verage Weighted remaining Number average contractual Aggregate of exercise term intrinsic options price in years Value Outstanding as of July 1, 2014 4,007,116 $ 2.13 6.82 $ 6,384 Granted 2,183,563 $ 4.89 Exercised (31,981 ) $ 2.36 Forfeited or expired (56,476 ) $ 3.42 Outstanding as of June 30, 2015 6,102,222 $ 3.10 7.08 $ 202,889 Vested and expected to vest as of June 30, 2015 5,809,767 $ 3.04 7.00 $ 193,518 Exercisable as of June 30, 2015 3,551,239 $ 2.17 5.71 $ 121,373 Weighted a verage Weighted remaining Number average contractual Aggregate of exercise term intrinsic options price in years Value Outstanding as of July 1, 2013 3,625,366 $ 1.92 7.39 $ 5,757 Granted 575,457 $ 3.41 Exercised (27,459 ) $ 1.86 Forfeited or expired (166,248 ) $ 2.16 Outstanding as of June 30, 2014 4,007,116 $ 2.13 6.82 $ 6,384 Vested and expected to vest as of June 30, 2014 3,746,620 $ 2.07 6.69 $ 6,175 Exercisable as of June 30, 2014 2,719,543 $ 1.81 6.08 $ 5,206
Schedule of exercise price range of options	Options Weighted Options Weighted outstanding average exercisable average Range of as of remaining as of remaining exercise June 30, contractual June 30, contractual price 201 5 Life in years 201 5 Life in years $ 0.87 557,605 3.94 490,165 3.14 $ 1.50 1.68 771,321 4.04 771,321 4.04 $ 2.01 2.46 2,075,550 6.30 1,794,228 6.24 $ 3.03 3.96 668,270 8.54 247,767 8.46 $ 5.01 5.04 1,996,148 9.42 247,758 9.40 $ 9.36 33,328 9.59 - - 6,102,222 7.08 3,551,239 5.71 Options Weighted Options Weighted outstanding average exercisable average Range of as of remaining as of remaining exercise June 30, contractual June 30, contractual price 201 4 L ife in years 201 4 L ife in years $ 0.87 490,165 4.14 490,165 4.14 $ 1.50 1.68 779,653 5.05 774,185 5.05 $ 2.01 2.46 2,114,517 7.31 1,388,628 7.19 $ 3.03 3.51 622,781 9.46 66,565 9.19 4,007,116 6.82 2,719,543 6.08
Option [Member] | Non-employee consultants [Member]
STOCK CAPITAL
Summary of the activity in the share options granted to employees and members of the board of directors	Options outstanding Exercisable as of as of Issuance June 30, Exercise June 30, Exercisable Date 2015 price 2015 Through July 31, 2008 33,333 $ 0.87 33,333 July 31, 2018 January 26, 2011 5,000 $ 2.01 5,000 January 26, 2021 January 26, 2012 33,333 $ 2.46 33,333 January 26, 2022 October 24, 2012 6,666 $ 2.46 4,583 October 24, 2022 January 23, 2013 3,333 $ 3.03 2,153 January 23, 2023 January 27, 2014 4,998 $ 3.51 1,652 January 27, 2024 May 1, 2014 6,000 $ 3.51 2,042 May 1, 2024 September 17, 2014 19,163 $ 3.96 3,662 September 17, 2024 October 29, 2014 6,668 $ 5.01 890 October 29, 2024 118,494 86,648 Options outstanding Exercisable as of as of Issuance June 30, Exercise June 30, Exercisable D ate 201 4 price 201 4 Through July 31, 2008 33,333 $ 0.87 33,333 July 31, 2018 January 26, 2011 5,000 $ 2.01 5,000 January 26, 2021 January 26, 2012 33,333 $ 2.46 27,778 January 26, 2022 October 24, 2012 6,666 $ 2.46 2,916 October 24, 2022 January 23, 2013 8,333 $ 3.03 3,298 January 23, 2023 January 27, 2014 4,998 $ 3.51 139 January 27, 2024 May 1, 2014 6,000 $ 3.51 - May 1, 2024 97,663 72,464
Schedule of recognized stock-based compensation expenses	Year ended 2015 2014 2013 Cost of revenues $ 442 $ 108 $ 88 Research and development, net 635 397 381 Selling and marketing 809 297 317 General and administrative 1,070 280 292 Total stock-based compensation expense $ 2,956 $ 1,082 $ 1,078

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Jun. 30, 2015
INCOME TAXES [Abstract]
Schedule of deferred tax liabilities and assets	June 30, 2015 2014 Assets in respect of: Carryforward tax losses (1) $ 23,033 $ 32,203 Research and Development carryforward expenses- temporary differences 5,173 4,310 Other reserves 1,346 786 29,552 37,299 Valuation allowance (2) (29,552 ) (37,299 ) Net deferred tax assets $ - $ - (1) See Note 14c. (2) The Company has provided full valuation allowances as of June 30, 2015 and 2014 on deferred tax assets resulting from carryforward tax losses, research and development carryforward expenses and other reserves due to its history of operating losses and current uncertainty concerning the ability to realize these deferred tax assets in the future.
Schedule of income (loss) before taxes	Year ended June 30, 2015 2014 Domestic $ 2,830 $ 661 Foreign 20,246 (21,819 ) $ 23,076 $ (21,158 )
Schedule of taxes on income	Year ended June 30, 2015 2014 2013 Federal $ 1,270 $ 11 $ - State 180 89 - Foreign 300 120 108 Taxes on income related to prior years 205 - - $ 1,955 $ 220 $ 108
Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)	Year ended June 30, 2015 2014 2013 Income (loss) before taxes, as reported in the consolidated statements of operations $ 23,076 $ (21,158 ) $ (28,072 ) Statutory tax rate 35 35 35 Theoretical tax benefits on the above amount at the US statutory tax rate 8,077 (7,405 ) (9,825 ) Income tax at rate other than the U.S. statutory tax rate (1,763 ) 2,007 2,167 Impact of Israel corporate tax rate change from 25% to 26.5% - (2,103 ) - Taxes on income related to prior years 205 - - Non-deductible expenses including equity based compensation expenses 3,003 467 300 Operating losses and other temporary differences for which valuation allowance was provided (7,747 ) 7,165 7,466 State tax 180 89 - Actual tax expense $ 1,955 $ 220 $ 108

FINANCIAL EXPENSES (INCOME), 37

FINANCIAL EXPENSES (INCOME), NET (Tables)	12 Months Ended
	Jun. 30, 2015
FINANCIAL EXPENSES (INCOME), NET [Abstract]
Schedule of financial expenses (income), net	Year ended June 30, 2015 2014 2013 Remeasurement of warrants to purchase convertible preferred stock $ 5,350 $ (53 ) $ 40 Interest on term loan 579 1,475 794 Other financial expenses related to term loan 373 31 21 Expenses (income) related to hedging transaction (1,721 ) 189 (207 ) Interest on short- term loan 316 537 276 Exchange rate loss (income), net, bank charges and other finance expenses 180 608 (312 ) $ 5,077 $ 2,787 $ 612

GEOGRAPHIC INFORMATION AND MA38

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Tables)	12 Months Ended
	Jun. 30, 2015
GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA [Abstract]
Summary of revenues within geographic areas	Year ended June 30, 2015 2014 2013 Revenues based on Customers' location: United States $ 238,340 $ 64,607 $ 15,334 Germany 13,290 15,133 12,692 Europe (*) 52,163 38,655 40,367 Rest of the World 21,285 14,822 10,642 Total revenues $ 325,078 $ 133,217 $ 79,035 (*) Except for Germany
Schedule of major customers data as percentage of total revenues	Year ended June 30, 2015 2014 2013 Customer A 24.6 19.1% * *) Less than 10%.
Summary of revenues by product family	Year ended June 30, 2015 2014 2013 Inverters $ 156,984 $ 62,085 $ 35,422 Optimizers 158,513 65,018 38,337 Others 9,581 6,114 5,276 Total revenues $ 325,078 $ 133,217 $ 79,035
Schedule of long-lived assets by geographic region	Year ended June 30, 2015 2014 Israel $ 14,136 $ 5,025 Europe 230 211 U.S. 342 112 Other 9 3 Total long-lived assets* $ 14,717 $ 5,351 * Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).

GENERAL (Details)

GENERAL (Details) $ in Thousands	Jun. 30, 2015	Mar. 31, 2015USD ($)shares	Jun. 30, 2014	Jun. 30, 2015item	Jun. 30, 2014	Jun. 17, 2015shares
General [Line Items]
Number of shares of common stock sold to the public		8,050,000
Number of shares of common stock sold pursuant to the full exercise of an overallotment option granted to the underwriters		1,050,000
Aggregate net proceeds received from offerings | $		$ 131,208
Convertible preferred stock converted into number of shares of common stock		28,247,923
Warrants to purchase number of shares of common stock		187,671				187,671
Number of contract manufacturers | item				2
Number of vendors | item				2
Consolidated revenues [Member] | Major customer [Member]
General [Line Items]
Percentage of customer revenue	24.60%		19.10%
Trade payables [Member] | Lender [Member]
General [Line Items]
Percentage of customer revenue				79.00%	60.00%

SIGNIFICANT ACCOUNTING POLICI40

SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details) - USD ($) $ in Thousands	Apr. 12, 2009	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Financial statements in U.S. dollars
Accumulated other comprehensive loss related to foreign currency translation adjustments, net		$ 222	$ 61	$ 26
Basic and Diluted Net Earnings (Loss) Per Share
Total weighted average number of shares related to the outstanding stock options, convertible preferred stock and warrants to purchase convertible preferred stock, excluded from the calculation of diluted net earnings (loss) per share due to their anti-dilutive effect		20,565,747	25,234,818	22,953,263
Impairment of long-lived assets
Impairment losses		$ 0	$ 0	$ 0
Severance pay
Severance expenses		$ 1,273	1,109	974
Revenue recognition
Estimated service period		25 years
Shipping and handling costs
Shipping and handling costs		$ 26,931	14,066	5,140
Warranty obligations
Minimum term of warranty obligations for inverters		12 years
Minimum term of warranty obligations for power optimizers		25 years
Maximum extended product warranty period		25 years
Royalty bearing grant
Amount received as royalty grant	$ 703			$ 248
Government grants
Government grants received		$ 763	$ 275

SIGNIFICANT ACCOUNTING POLICI41

SIGNIFICANT ACCOUNTING POLICIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Numerator:
Net income (loss)	$ 21,121	$ (21,378)	$ (28,180)
Dividends accumulated for the period	(17,550)
Net income (loss) available to shareholders of common stock	$ 3,571	$ (21,378)	$ (28,180)
Denominator:
Shares used in computing net earnings (loss) per share of common stock, basic (in shares)	11,902,911	2,798,894	2,741,370
Numerator:
Net income (loss)	$ 21,121	$ (21,378)	$ (28,180)
Dividends accumulated for the period	(16,971)
Net income (loss) available to shareholders of common stock	$ 4,150	$ (21,378)	$ (28,180)
Denominator:
Shares used in computing net earnings (loss) per share of common stock, diluted (in shares)	15,269,448	2,798,894	2,741,370

SIGNIFICANT ACCOUNTING POLICI42

SIGNIFICANT ACCOUNTING POLICIES (Estimated Useful Lives of Property and Equipment) (Details) - 12 months ended Jun. 30, 2015	Total
Computer and peripheral equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Computer and peripheral equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	14.00%
Computer and peripheral equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Office furniture and equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	7.00%
Office furniture and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	7.00%
Office furniture and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Machinery & equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	20.00%
Machinery & equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	7.00%
Machinery & equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Laboratory equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Laboratory equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Laboratory equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	33.00%
Vehicles [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, depreciation rate	15.00%
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives of assets	over the shorter of the lease term or useful economic life

SIGNIFICANT ACCOUNTING POLICI43

SIGNIFICANT ACCOUNTING POLICIES (Concentrations of Credit risks) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Concentration Risk [Line Items]
Accrued allowance for doubtful accounts	$ 13
Derivative financial instruments
Fair value of derivative instruments	$ 859	$ 213	$ 258
Trade receivables [Member] | Customer [Member]
Concentration Risk [Line Items]
Percentage of customer revenue	30.00%	31.00%

SIGNIFICANT ACCOUNTING POLICI44

SIGNIFICANT ACCOUNTING POLICIES (Estimate Fair Value of Stock Options and Warrants) (Details)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Volatility rate		45.00%	55.80%
Risk-free rate		0.09%	0.30%
Dividend yield		0.00%	0.00%
Expected term (in years)		1 year 2 months 16 days	1 year 6 months
Stock Option [Member] | Employee and Executive Director [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum volatility rate	46.50%	46.30%	55.80%
Maximum volatility rate	55.10%	55.80%	62.70%
Risk-free rate minimum	1.39%	1.62%	0.74%
Risk-free rate maximum	2.06%	1.94%	1.00%
Dividend yield	0.00%	0.00%	0.00%
Estimated forfeiture rate		14.00%
Stock Option [Member] | Employee and Executive Director [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	5 years 6 months	6 years 7 days	6 years 29 days
Estimated forfeiture rate	12.50%		14.50%
Stock Option [Member] | Employee and Executive Director [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years 3 months 7 days	6 years 3 months 7 days	6 years 3 months 7 days
Estimated forfeiture rate	18.70%		20.90%
Stock Option [Member] | Non-employee Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Minimum volatility rate	45.50%	45.00%	55.80%
Maximum volatility rate	56.20%	55.80%	62.70%
Risk-free rate minimum	1.49%	1.95%	0.98%
Risk-free rate maximum	2.58%	2.45%	1.96%
Dividend yield	0.00%	0.00%	0.00%
Stock Option [Member] | Non-employee Consultants [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	7 years 2 months 12 days	6 years	7 years
Stock Option [Member] | Non-employee Consultants [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	10 years	10 years	10 years

SIGNIFICANT ACCOUNTING POLICI45

SIGNIFICANT ACCOUNTING POLICIES (Schedule of Change in Fair Value of Warrants) (Details) - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013	Jun. 17, 2015	Mar. 31, 2015
Change in fair value of warrants to purchase convertible preferred stock
Balance at beginning of period		$ 765	$ 818
Issuance of warrants to purchase preferred stock				$ 778
Exercise of warrants to purchase preferred stock	[1]	$ (6,115)
Change in fair value		$ 5,350	$ (53)	$ 40
Balance at end of period			$ 765	$ 818
Warrants to purchase number of shares of common stock					187,671	187,671
Cashless warrants exercised into common shares		154,768
[1]	Upon the closing of the IPO, all outstanding warrants to purchase convertible preferred stock automatically converted into warrants to purchase 187,671 shares of common stock (See Note 1b).

PREPAID EXPENSES AND OTHER AC46

PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE (Details) - USD ($) $ in Thousands		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
PREPAID EXPENSES AND OTHER ACCOUNTS RECEIVABLE [Abstract]
Contract manufacturers	[1]	$ 24,814	$ 10,234
Government authorities		3,729	$ 646
OCS		249
Prepaid expenses and other		2,994	$ 2,038
Foreign currency derivative contracts		$ 859	213	$ 258
Deferred charges (see Note 8)			20
Prepaid expenses and other accounts receivable		$ 32,645	13,151
Foreign currency derivative contracts		$ 859	$ 213
[1]	Contract manufacturers receivables derive from the sale of components to manufacturing vendors who manufacture products for the Company. The Company purchases these components directly from suppliers. The Company does not reflect the sale of these components in revenues (see also Note 10e).

INVENTORIES (Details)

INVENTORIES (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INVENTORIES [Abstract]
Raw materials	$ 14,405	$ 7,750
Finished goods	59,545	17,749
Inventories	73,950	25,499
Write-down amount of inventory	$ 992	$ 1,131	$ 428

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details) - USD ($) $ in Thousands		12 Months Ended
		Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
PROPERTY AND EQUIPMENT [Line Items]
Cost		$ 22,119	$ 12,297
Less - accumulated depreciation		7,402	6,946
Depreciated cost	[1]	14,717	5,351
Depreciation expenses		2,253	1,978	$ 1,842
Computers and peripheral equipment [Member]
PROPERTY AND EQUIPMENT [Line Items]
Cost		3,139	3,193
Office furniture and equipment [Member]
PROPERTY AND EQUIPMENT [Line Items]
Cost		779	404
Laboratory and testing equipment [Member]
PROPERTY AND EQUIPMENT [Line Items]
Cost		7,205	5,856
Machinery and equipment [Member]
PROPERTY AND EQUIPMENT [Line Items]
Cost		6,936	2,491
Leasehold improvements [Member]
PROPERTY AND EQUIPMENT [Line Items]
Cost		4,047	$ 353
Vehicles [Member]
PROPERTY AND EQUIPMENT [Line Items]
Cost		$ 13
[1]	Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).

ACCRUED EXPENSES AND OTHER AC49

ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE (Details) - USD ($) $ in Thousands		Jun. 30, 2015	Jun. 30, 2014
ACCRUED EXPENSES AND OTHER ACCOUNTS PAYABLE [Abstract]
Accrued expenses		$ 5,271	$ 2,807
Provision for contractual inventory purchase obligations	[1]	$ 1,304	1,317
OCS			$ 146
Other		$ 412
Accrued expenses and other accounts payable		$ 6,987	$ 4,270
[1]	* See also Note 10e.

WARRANTY OBLIGATIONS (Details)

WARRANTY OBLIGATIONS (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Changes in the Company's product warranty liability
Balance, at beginning of year	$ 18,181	$ 10,378
Additions and adjustments to cost of revenues	19,407	11,861
Usage and current warranty expenses	(5,709)	(4,058)
Balance, at end of year	31,879	18,181
Less current portion	(9,431)	(5,496)
Long term portion	$ 22,448	$ 12,685

TERM LOAN AND WARRANTS TO PUR51

TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK (Details) $ / shares in Units, $ in Thousands	Dec. 28, 2012USD ($)item$ / sharesshares	Jun. 30, 2015USD ($)shares	Jun. 30, 2014USD ($)	Jun. 30, 2013USD ($)	Jun. 17, 2015shares	Mar. 31, 2015shares
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Line Items]
Proceeds from loans				$ 9,900
Loan transaction fee paid				$ 100
Warrants granted to lender | shares					187,671	187,671
Cashless warrants exercised into common shares | shares		154,768
Fair value of the Warrants liability reclassified to stockholders' equity		$ 6,115
Term loan [Member]
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Line Items]
Loan amount	$ 10,000
Proceeds from loans	10,000
Loan transaction fee paid	$ 100
Debt instrument maturity period	42 months
Interest rate (as a percent)	11.90%
Number of monthly payments in which principal of loan to be paid | item	33
Warrant intrinsic value threshold	$ 750
Warrant liability at fair value	778		$ 765
Residual amount	9,122
Issuance expense allocated to the warrants liability and to the loan	75
Issuance expenses related to the Warrants liability immediately expensed and recorded as financial expenses, net	6
Issuance expenses related to the Loan recorded as deferred charge assets	$ 69
Term loan [Member] | Series D-1 convertible preferred stock [Member]
TERM LOAN AND WARRANTS TO PURCHASE CONVERTIBLE PREFERRED STOCK [Line Items]
Warrants granted to lender | shares	563,014
Exercise price of warrants (in dollars per share) | $ / shares	$ 2.309
Period after a qualified initial public offering considered while deciding warrants exercisability	12 months

REVOLVING CREDIT LINE (Details)

REVOLVING CREDIT LINE (Details) - Revolving line of credit [Member] - USD ($) $ in Thousands	1 Months Ended		12 Months Ended
	Feb. 28, 2015	Jun. 30, 2011	Jun. 30, 2015	Mar. 31, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2014
REVOLVING CREDIT LINE [Line Items]
Aggregate borrowings	$ 40,000	$ 20,000
Maximum specified percentage of eligible trade receivables considered for determining maximum borrowing capacity	80.00%	80.00%
Maximum specified percentage of inventories in transit considered for determining maximum borrowing capacity		65.00%
Description of variable rate basis	Bank Lender's prime rate		Bank Lender's prime rate
Average interest rate (as a percent)							4.90%
Termination date	Dec. 31, 2016
Maximum non-cash stock-based compensation considered calculation of net income	$ (1,500)
Minimum positive Adjusted EBITDA as of June 30, 2015			$ 1,500
Minimum positive Adjusted EBITDA quarterly				$ 1,500	$ 3,500	$ 3,500
Minimum positive Adjusted EBITDA as of June 30, 2016			3,500
Amount of liquidity need to maintain	$ 6,750
Outstanding borrowings			$ 0
Minimum [Member]
REVOLVING CREDIT LINE [Line Items]
Applicable margin (as a percent)	0.50%		0.75%
Maximum [Member]
REVOLVING CREDIT LINE [Line Items]
Applicable margin (as a percent)	2.00%		2.75%

COMMITMENTS AND CONTINGENT LI53

COMMITMENTS AND CONTINGENT LIABILITIES (Schedule of Future Minimum Lease Commitments) (Details) $ in Thousands	Jun. 30, 2015USD ($)
Future minimum lease commitments
2,016	$ 2,256
2,017	2,218
2,018	2,156
2,019	2,042
2020 and thereafter	8,706
Future minimum lease commitments amount	$ 17,378

COMMITMENTS AND CONTINGENT LI54

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Lease commitments, Guarantees, Royalty commitments, Governmental commitments, Contractual purchase obligations) (Details) - USD ($) $ in Thousands		Apr. 12, 2009	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Lease commitments
Contract term			10 years
Rent expenses			$ 1,714	$ 1,200	$ 1,212
Royalty commitments
Amount received as royalty grant		$ 703			$ 248
Royalties payment percentage of gross sales of products developed with funds provided by the BIRD-F			5.00%
Royalties payment subject to maximum percentage of research and development grants			150.00%
Aggregate contingent liability to the BIRD-F amount			$ 1,135
Governmental commitments
Royalties payment percentage to OCS for first three years			4.00%
Royalties percentage of 4% for number of years			3 years
Royalties payment percentage to OCS for thereafter years			4.50%
Maximum royalties percentage of grants received			100.00%
Governmental commitments amount			$ 771
Royalties payables			0	0
Contractual purchase obligations
Non-cancelable purchase obligations			92,071
Provision for contractual inventory purchase obligations	[1]		1,304	$ 1,317
Office rent lease agreements [Member]
Guarantees [line Items]
Guarantees amount			813
Customs transactions [Member]
Guarantees [line Items]
Guarantees amount			53
Credit card limits [Member]
Guarantees [line Items]
Guarantees amount			$ 85
[1]	* See also Note 10e.

COMMITMENTS AND CONTINGENT LI55

COMMITMENTS AND CONTINGENT LIABILITIES (Narrative) (Legal claims) (Details) - Appletech [Member] $ in Thousands	Jul. 24, 2014USD ($)	Jul. 24, 2014ILS (₪)	Jun. 30, 2014USD ($)	Jun. 30, 2014ILS (₪)
Legal claims [Line Items]
Loss contingency accrual amount			$ 642	₪ 2,208,000
Payment made to plaintiff	$ 502	₪ 1,725,000
Maximum payment period	45 days	45 days

LEASE INCENTIVE OBLIGATION (Det

LEASE INCENTIVE OBLIGATION (Details) $ in Thousands	Jun. 30, 2015USD ($)
LEASE INCENTIVE OBLIGATION [Abstract]
Operating lease receivable	$ 2,811
Received in cash from the Lessor	$ 2,313

CONVERTIBLE PREFERRED STOCK (Co

CONVERTIBLE PREFERRED STOCK (Composition of Convertible Preferred Stock) (Details) - $ / shares		Jun. 30, 2015	Jun. 30, 2014
Temporary Equity [Line Items]
Authorized, Number of shares		95,000,000	80,772,775
Issued, Number of shares		0	75,422,773
Outstanding, Number of shares		0	75,422,773
Convertible preferred stock, par value		$ 0.0001	$ 0.0001
Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares		95,000,000
Issued, Number of shares
Outstanding, Number of shares
Series A Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares			15,558,830
Issued, Number of shares			15,558,830
Outstanding, Number of shares			15,558,830
Convertible preferred stock, par value			$ 0.0001
Series B Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares			19,010,196
Issued, Number of shares			18,760,196
Outstanding, Number of shares			18,760,196
Convertible preferred stock, par value			$ 0.0001
Series C Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares			15,984,655
Issued, Number of shares			15,984,655
Outstanding, Number of shares			15,984,655
Convertible preferred stock, par value			$ 0.0001
Series D Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares			16,024,251
Issued, Number of shares			16,024,251
Outstanding, Number of shares			16,024,251
Convertible preferred stock, par value			$ 0.0001
Series D-1 Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares			5,100,000
Issued, Number of shares			2,165,441
Outstanding, Number of shares			2,165,441
Convertible preferred stock, par value			$ 0.0001
Series D-2 Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares	[1]		2,598,528
Issued, Number of shares	[1]		2,598,528
Outstanding, Number of shares	[1]		2,598,528
Convertible preferred stock, par value			$ 0.0001
Series D-3 Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares			6,496,315
Issued, Number of shares			4,330,872
Outstanding, Number of shares			4,330,872
Convertible preferred stock, par value			$ 0.0001
Series E Preferred stock [Member]
Temporary Equity [Line Items]
Authorized, Number of shares	[2]
Issued, Number of shares	[2]
Outstanding, Number of shares	[2]
[1]	As of June 30, 2013, a total of $5,314 was received on account of preferred stock. The related 2,304,524 Series D-2 preferred stock were issued in July 2013.
[2]	In September 2014, the Company entered into a stock purchase agreement with new investors, pursuant to which the Company issued 9,321,019 shares of the Company's Series E Convertible Preferred stock for cash consideration of $25,000, which was received by the end of October 2014.

CONVERTIBLE PREFERRED STOCK (Na

CONVERTIBLE PREFERRED STOCK (Narrative) (Details) - USD ($) $ in Thousands	1 Months Ended			12 Months Ended
	Mar. 31, 2015	Sep. 30, 2014	Jul. 31, 2013	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Convertible Preferred Stock [Line Items]
Amount received on account of preferred stock						$ 5,314
Classification of convertible preferred stock temporary equity into stockholders' equity (deficiency)	$ 140,915
Series D-2 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Amount received on account of preferred stock						$ 5,314
Stock issued for cash consideration (in shares)			2,304,524
Stock issued for cash consideration
Series E Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Stock issued for cash consideration (in shares)		9,321,019
Stock issued for cash consideration		$ 25,000

CONVERTIBLE PREFERRED STOCK (Sc

CONVERTIBLE PREFERRED STOCK (Schedule of convertible preferred stock outstanding prior to consummation of IPO) (Details)	12 Months Ended
	Jun. 30, 2015shares
Convertible Preferred Stock [Line Items]
Shares Outstanding	84,743,792
Number of Shares of Common Stock issued upon conversion	28,247,923
Series A Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	15,558,830
Number of Shares of Common Stock issued upon conversion	5,186,276
Series B Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	18,760,196
Number of Shares of Common Stock issued upon conversion	6,253,398
Series C Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	15,984,655
Number of Shares of Common Stock issued upon conversion	5,328,217
Series D Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	16,024,251
Number of Shares of Common Stock issued upon conversion	5,341,416
Series D-1 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	2,165,441
Number of Shares of Common Stock issued upon conversion	721,813
Series D-2 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	2,598,528
Number of Shares of Common Stock issued upon conversion	866,175
Series D-3 Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	4,330,872
Number of Shares of Common Stock issued upon conversion	1,443,623
Series E Preferred stock [Member]
Convertible Preferred Stock [Line Items]
Shares Outstanding	9,321,019
Number of Shares of Common Stock issued upon conversion	3,107,005

STOCK CAPITAL (Common Stock) (D

STOCK CAPITAL (Common Stock) (Details)	12 Months Ended
	Jun. 30, 2015item$ / sharesshares	Jun. 30, 2014$ / sharesshares
STOCK CAPITAL [Abstract]
Reverse stock split ratio	3
Common stock capital
Par value | $ / shares	$ 0.0001	$ 0.0001
Authorized	125,000,000	34,939,461
Common stock, issued shares	39,297,539	2,809,950
Common stock, outstanding shares	39,297,539	2,809,950
Number of votes per share | item	1

STOCK CAPITAL (Stock option pla

STOCK CAPITAL (Stock option plans) (Details) - USD ($) $ / shares in Units, $ in Thousands	Dec. 31, 2014	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Stock option plans
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		10,000,000
Employees and members of the board of directors [Member] | Maximum [Member] | 2015 Plan
Stock option plans
Percentage of common shares increase automatically in each year	5.00%
Option [Member]
Stock option plans
Number of options are available for future grant under the plan		379,358
Unrecognized compensation expense		$ 10,577
Option [Member] | 2015 Plan
Stock option plans
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		1,822,484
Number of options are available for future grant under the plan		1,755,044
Percentage of common shares increase automatically in each year		5.00%
Option [Member] | Employees and members of the board of directors [Member]
Stock option plans
Intrinsic value of options exercised		$ 484	$ 58
Weighted average grant date fair values options granted to employees and executive directors		$ 7.57	$ 0.66	$ 0.52
ESPP [Member]
Stock option plans
Number of shares of common stock reserved for issuance pursuant to stock awards under the plan		487,643
Period of plan increase automatically number of shares		10 years
Percentage of common shares increase automatically in each year		1.00%

STOCK CAPITAL (Summary of the a

STOCK CAPITAL (Summary of the activity in the share options) (Details) - Option [Member] - Employees and members of the board of directors [Member] - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Number of options
Outstanding at the beginning of the period	4,007,116	3,625,366
Granted	2,183,563	575,457
Exercised	(31,981)	(27,459)
Forfeited or expired	(56,476)	(166,248)
Outstanding at the end of the period	6,102,222	4,007,116	3,625,366
Weighted average exercise price
Outstanding at the beginning of the period	$ 2.13	$ 1.92
Granted	4.89	3.41
Exercised	2.36	1.86
Forfeited or expired	3.42	2.16
Outstanding at the end of the period	$ 3.10	$ 2.13	$ 1.92
Weighted average remaining contractual term in years
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	7 years 29 days	6 years 9 months 25 days	7 years 4 months 20 days
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	7 years 29 days	6 years 9 months 25 days	7 years 4 months 20 days
Aggregate intrinsic Value
Outstanding at the beginning of the period	$ 6,384	$ 5,757
Outstanding at the end of the period	$ 202,889	$ 6,384	$ 5,757
Vested and expected to vest at the end of the period
Number of options	5,809,767	3,746,620
Weighted average exercise price	$ 3.04	$ 2.07
Weighted average remaining contractual term in years	7 years	6 years 8 months 8 days
Aggregate intrinsic Value	$ 193,518	$ 6,175
Exercisable at the end of the period
Number of options	3,551,239	2,719,543
Weighted average exercise price	$ 2.17	$ 1.81
Weighted average remaining contractual term in years	5 years 8 months 16 days	6 years 29 days
Aggregate intrinsic Value	$ 121,373	$ 5,206

STOCK CAPITAL (Schedule of exer

STOCK CAPITAL (Schedule of exercise price ranges) (Details) - Employees and members of the board of directors [Member] - $ / shares	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Range of exercise price [Line Items]
Options outstanding	6,102,222	4,007,116
Weighted average remaining contractual Life in years	7 years 29 days	6 years 9 months 25 days
Options exercisable	3,551,239	2,719,543
Weighted average remaining contractual Life in years	5 years 8 months 16 days	6 years 29 days
$0.87 [Member]
Range of exercise price [Line Items]
Exercise price	$ 0.87	$ 0.87
Options outstanding	557,605	490,165
Weighted average remaining contractual Life in years	3 years 11 months 8 days	4 years 1 month 20 days
Options exercisable	490,165	490,165
Weighted average remaining contractual Life in years	3 years 1 month 20 days	4 years 1 month 20 days
$1.50 - $1.68 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 1.50	$ 1.50
Range of exercise price, upper	$ 1.68	$ 1.68
Options outstanding	771,321	779,653
Weighted average remaining contractual Life in years	4 years 14 days	5 years 18 days
Options exercisable	771,321	774,185
Weighted average remaining contractual Life in years	4 years 14 days	5 years 18 days
$2.01 - $2.46 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 2.01	$ 2.01
Range of exercise price, upper	$ 2.46	$ 2.46
Options outstanding	2,075,550	2,114,517
Weighted average remaining contractual Life in years	6 years 3 months 18 days	7 years 3 months 22 days
Options exercisable	1,794,228	1,388,628
Weighted average remaining contractual Life in years	6 years 2 months 26 days	7 years 2 months 8 days
$3.03 - $3.51 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower		$ 3.03
Range of exercise price, upper		$ 3.51
Options outstanding		622,781
Weighted average remaining contractual Life in years		9 years 5 months 16 days
Options exercisable		66,565
Weighted average remaining contractual Life in years		9 years 2 months 8 days
$3.03 - $3.96 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 3.03
Range of exercise price, upper	$ 3.96
Options outstanding	668,270
Weighted average remaining contractual Life in years	8 years 6 months 14 days
Options exercisable	247,767
Weighted average remaining contractual Life in years	8 years 5 months 16 days
$5.01 - $5.04 [Member]
Range of exercise price [Line Items]
Range of exercise price, lower	$ 5.01
Range of exercise price, upper	$ 5.04
Options outstanding	1,996,148
Weighted average remaining contractual Life in years	9 years 5 months 1 day
Options exercisable	247,758
Weighted average remaining contractual Life in years	9 years 4 months 24 days
$9.36 [Member]
Range of exercise price [Line Items]
Exercise price	$ 9.36
Options outstanding	33,328
Weighted average remaining contractual Life in years	9 years 7 months 2 days
Options exercisable
Weighted average remaining contractual Life in years

STOCK CAPITAL (Options issued t

STOCK CAPITAL (Options issued to non-employee consultants) (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Stock option plans
Stock compensation expenses	$ 2,956	$ 1,082	$ 1,078
Option [Member] | Non-employee consultants [Member]
Stock option plans
Options outstanding at the end of the period	118,494	97,663
Exercisable at the end of the period	86,648	72,464
Stock compensation expenses	$ 563	$ 55	$ 45
Option [Member] | Non-employee consultants [Member] | July 31, 2008
Stock option plans
Options outstanding at the end of the period	33,333	33,333
Exercise price	$ 0.87	$ 0.87
Exercisable at the end of the period	33,333	33,333
Option [Member] | Non-employee consultants [Member] | January 26, 2011
Stock option plans
Options outstanding at the end of the period	5,000	5,000
Exercise price	$ 2.01	$ 2.01
Exercisable at the end of the period	5,000	5,000
Option [Member] | Non-employee consultants [Member] | January 26, 2012
Stock option plans
Options outstanding at the end of the period	33,333	33,333
Exercise price	$ 2.46	$ 2.46
Exercisable at the end of the period	33,333	27,778
Option [Member] | Non-employee consultants [Member] | October 24, 2012
Stock option plans
Options outstanding at the end of the period	6,666	6,666
Exercise price	$ 2.46	$ 2.46
Exercisable at the end of the period	4,583	2,916
Option [Member] | Non-employee consultants [Member] | January 23, 2013
Stock option plans
Options outstanding at the end of the period	3,333	8,333
Exercise price	$ 3.03	$ 3.03
Exercisable at the end of the period	2,153	3,298
Option [Member] | Non-employee consultants [Member] | January 27, 2014
Stock option plans
Options outstanding at the end of the period	4,998	4,998
Exercise price	$ 3.51	$ 3.51
Exercisable at the end of the period	1,652	139
Option [Member] | Non-employee consultants [Member] | May 1, 2014
Stock option plans
Options outstanding at the end of the period	6,000	6,000
Exercise price	$ 3.51	$ 3.51
Exercisable at the end of the period	2,042
Option [Member] | Non-employee consultants [Member] | September 17, 2014
Stock option plans
Options outstanding at the end of the period	19,163
Exercise price	$ 3.96
Exercisable at the end of the period	3,662
Option [Member] | Non-employee consultants [Member] | October 29, 2014
Stock option plans
Options outstanding at the end of the period	6,668
Exercise price	$ 5.01
Exercisable at the end of the period	890

STOCK CAPITAL (Schedule of stoc

STOCK CAPITAL (Schedule of stock-based compensation expense for employees and non-employee consultants) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Stock-based compensation expenses
Total stock-based compensation expense	$ 2,956	$ 1,082	$ 1,078
Cost of revenues [Member]
Stock-based compensation expenses
Total stock-based compensation expense	442	108	88
Research and development, net [Member]
Stock-based compensation expenses
Total stock-based compensation expense	635	397	381
Selling and marketing [Member]
Stock-based compensation expenses
Total stock-based compensation expense	809	297	317
General and administrative [Member]
Stock-based compensation expenses
Total stock-based compensation expense	$ 1,070	$ 280	$ 292

INCOME TAXES (Narratives) (Deta

INCOME TAXES (Narratives) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)	35.00%	35.00%	35.00%
Net carryforward tax losses
Germany [Member] | Subsidiaries [Member]
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)	33.00%
Israel [Member] | Subsidiaries [Member]
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)	26.50%	26.50%	25.00%
Net carryforward tax losses	$ 84,700
Amortization period for patents and know-how for industrial company	8 years
Amortization period for deferred expenses related to public offering for industrial company	3 years
Israel [Member] | Subsidiaries [Member] | Beneficiary Enterprise [Member]
INCOME TAXES [Line Items]
Period for which productive activity will be exempt from tax under Investment Law				2 years
Period from beginning of the year of election for which tax benefit is available under Investment Law				12 years
Dividend tax rate (as a percent)				15.00%
Israel [Member] | Subsidiaries [Member] | Preferred Enterprise [Member]
INCOME TAXES [Line Items]
Corporate tax rate (as a percent)		16.00%
Dividend tax rate (as a percent)	20.00%
California [Member]
INCOME TAXES [Line Items]
Net carryforward tax losses	$ 9,794
Expiration date of tax carryforward	Jan. 1, 2031

INCOME TAXES (Schedule of Defer

INCOME TAXES (Schedule of Deferred Tax Liabilities And Assets) (Details) - USD ($) $ in Thousands		Jun. 30, 2015	Jun. 30, 2014
Assets in respect of:
Carryforward tax losses	[1]	$ 23,033	$ 32,203
Research and Development carryforward expenses- temporary differences		5,173	4,310
Other reserves		1,346	786
Deferred tax assets, gross		29,552	37,299
Valuation allowance	[2]	$ 29,552	$ 37,299
Net deferred tax assets
[1]	See Note 14c.
[2]	The Company has provided full valuation allowances as of June 30, 2015 and 2014 on deferred tax assets resulting from carryforward tax losses, research and development carryforward expenses and other reserves due to its history of operating losses and current uncertainty concerning the ability to realize these deferred tax assets in the future.

INCOME TAXES (Schedule of Incom

INCOME TAXES (Schedule of Income (Loss) Before Taxes) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INCOME TAXES [Abstract]
Domestic	$ (2,830)	$ (661)
Foreign	(20,246)	21,819
Income (loss) before taxes on income	$ 23,076	$ (21,158)	$ (28,072)

INCOME TAXES (Schedule of Taxes

INCOME TAXES (Schedule of Taxes on Income) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INCOME TAXES [Abstract]
Federal	$ 1,270	$ 11
State	180	89
Foreign	300	$ 120	$ 108
Taxes on income related to prior years	205
Taxes on loss	$ 1,955	$ 220	$ 108

INCOME TAXES (Schedule of recon

INCOME TAXES (Schedule of reconciliation between the theoretical tax expense and the actual tax expense (benefit)) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
INCOME TAXES [Abstract]
Income (loss) before taxes, as reported in the consolidated statements of operations	$ 23,076	$ (21,158)	$ (28,072)
Statutory tax rate (as a percent)	35.00%	35.00%	35.00%
Theoretical tax benefits on the above amount at the US statutory tax rate	$ 8,077	$ (7,405)	$ (9,825)
Income tax at rate other than the U.S. statutory tax rate	$ (1,763)	2,007	$ 2,167
Impact of Israel corporate tax rate change from 25% to 26.5%		$ (2,103)
Taxes on income related to prior years	$ 205
Non-deductible expenses including equity based compensation expenses	3,003	$ 467	$ 300
Operating losses and other temporary differences for which valuation allowance was provided	(7,747)	7,165	$ 7,466
State tax	180	89
Actual tax expense	$ 1,955	$ 220	$ 108

FINANCIAL EXPENSES (INCOME), 71

FINANCIAL EXPENSES (INCOME), NET (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
FINANCIAL EXPENSES (INCOME), NET [Abstract]
Remeasurement of warrants to purchase convertible preferred stock	$ 5,350	$ (53)	$ 40
Interest on term loan	579	1,475	794
Other financial expenses related to term loan	373	31	21
Expenses (income) related to hedging transaction	(1,721)	189	(207)
Interest on short-term loan	316	537	276
Exchange rate loss (income), net, bank charges and other finance expenses	180	608	(312)
Financial expenses (income), net	$ 5,077	$ 2,787	$ 612

GEOGRAPHIC INFORMATION AND MA72

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Summary of Revenues Within Geographic Areas) (Details) $ in Thousands		12 Months Ended
		Jun. 30, 2015USD ($)item	Jun. 30, 2014USD ($)	Jun. 30, 2013USD ($)
GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA [Abstract]
Number of reportable segments | item		1
Revenues within geographic areas [Line Items]
Total revenues		$ 325,078	$ 133,217	$ 79,035
United States [Member]
Revenues within geographic areas [Line Items]
Total revenues		238,340	64,607	15,334
Germany [Member]
Revenues within geographic areas [Line Items]
Total revenues		13,290	15,133	12,692
Europe [Member]
Revenues within geographic areas [Line Items]
Total revenues	[1]	52,163	38,655	40,367
Rest of the World [Member]
Revenues within geographic areas [Line Items]
Total revenues		$ 21,285	$ 14,822	$ 10,642
[1]	Except for Germany

GEOGRAPHIC INFORMATION AND MA73

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Schedule of Major Customers Data As a Percentage of Total Revenues) (Details)	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013	[1]
Revenues [Member] | Major customer [Member] | Customer A [Member]
Revenue, Major Customer [Line Items]
Percentage of customer revenue	24.60%	19.10%
[1]	Less than 10%.

GEOGRAPHIC INFORMATION AND MA74

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Summary of Revenues by Product Family) (Details) - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2013
Revenues by product family [Line Items]
Total revenues	$ 325,078	$ 133,217	$ 79,035
Inverters [Member]
Revenues by product family [Line Items]
Total revenues	156,984	62,085	35,422
Optimizers [Member]
Revenues by product family [Line Items]
Total revenues	158,513	65,018	38,337
Others [Member]
Revenues by product family [Line Items]
Total revenues	$ 9,581	$ 6,114	$ 5,276

GEOGRAPHIC INFORMATION AND MA75

GEOGRAPHIC INFORMATION AND MAJOR CUSTOMER AND PRODUCT DATA (Schedule of Long-Lived Assets by Geographic Region) (Details) - USD ($) $ in Thousands		Jun. 30, 2015	Jun. 30, 2014
Long-lived assets by geographic region [Line Items]
Total long-lived assets	[1]	$ 14,717	$ 5,351
Israel [Member]
Long-lived assets by geographic region [Line Items]
Total long-lived assets		14,136	5,025
Europe [Member]
Long-lived assets by geographic region [Line Items]
Total long-lived assets		230	211
U.S. [Member]
Long-lived assets by geographic region [Line Items]
Total long-lived assets		342	112
Other [Member]
Long-lived assets by geographic region [Line Items]
Total long-lived assets		$ 9	$ 3
[1]	Long-lived assets are comprised of property and equipment, net (long term lease deposits and severance pay fund are not included).

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) $ in Thousands	1 Months Ended
	Jul. 31, 2015USD ($)
Subsequent Event [Member]
Subsequent events [Line Items]
Payments for purchase of patents portfolio	$ 800